rfhg_64104.1

Basic information about the TSS

---

TSS ID: rfhg_64104.1 TSS ID(Version3): hg_50570.1 hg_50569.1 hg_50567.1 hg_50568.1 Species: human Chr: chr4		Start: 169620528 End: 169620723 Strand: +
Source datasets	FANTOM5|PRJNA548673|PRJNA401781|PRJNA615891|DRA013844 |PRJNA4843412|PRJDB5282
Protocol	CAGE|ReCappable-seq|RAMPAGE|SLIC_CAGE|NETCAGE|oligo_capping |TIF-seq2|C1CAGE
TSS cluster detected*	11

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000360642.7:0 ENST00000512813.5:0 ENST00000513761.6:0 BX647119:0 AK304362:0 X78520:0 BC054877:0 BC026256:0 GeneID: 1182 HGNC/MGI_ID: HGNC:2021 UniProt_ID: D6RIX3 P51790 Q7Z4M4 Nearer transcript ids and distances: ENST00000347613.8:-2 BC136510:114 AB019542:270 view more...

Gene_name: chloride voltage-gated channel 3 Gene_symbol: CLCN3 Gene_synonyms: CLC3 ClC-3 Gene_source: HGNC:2021

TATA-Box annotation

---

Distance to TSS:	47
Nearest PromoterID:	NM_001243372
Entrez ID:	1182
Nearest Unigene:	Hs.481186
Nearest Refseq:	NM_001829
Nearest Ensembl:	ENSG00000109572
Gene Name:	chloride voltage-gated channel 3
Gene Alias:	CLC3|ClC-3
Gene Type:	protein-coding
CpG%:	0.076923
GC%:	0.612245
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CLCN3 p2@CLCN3 p3@CLCN3 p4@CLCN3 p5@CLCN3 p6@CLCN3 p7@CLCN3 p8@CLCN3 p10@CLCN3
Sample		p1@CLCN3	p2@CLCN3	p3@CLCN3	p4@CLCN3	p5@CLCN3	p6@CLCN3	p7@CLCN3	p8@CLCN3	p10@CLCN3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	10.32	3.31	0.19	1.17	0.19	0.39	0.19	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	11.94	4.25	0.00	0.20	0.00	0.61	0.00	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	11.77	3.47	0.00	2.12	0.00	1.54	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	7.48	3.95	0.00	0.42	0.42	0.42	0.00	0.42	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	8.77	2.25	0.00	0.67	0.45	0.45	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	8.33	3.88	0.19	0.19	0.00	0.58	0.00	0.39	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	19.17	8.50	0.44	0.87	0.87	0.00	0.22	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	11.63	6.54	0.24	0.48	1.21	0.48	0.00	0.48	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	13.46	7.91	0.21	0.85	0.21	0.85	0.21	1.50	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	12.75	16.23	0.00	0.58	1.16	0.00	0.58	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	11.72	18.19	0.00	1.21	0.40	0.81	0.00	1.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	11.38	12.20	0.41	1.22	0.41	0.81	0.00	1.63	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	34.50	5.64	3.87	1.93	0.48	1.77	1.45	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	33.68	4.36	7.07	1.65	0.60	0.60	0.75	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	32.71	4.61	5.71	1.54	0.44	0.66	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	31.18	5.28	5.53	2.01	0.50	2.01	0.75	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	29.05	4.37	7.21	1.97	0.87	1.53	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	30.79	2.95	4.22	1.27	0.42	1.27	1.27	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	32.52	5.86	7.46	3.20	0.53	2.67	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	32.04	5.72	4.51	1.20	0.60	1.20	0.60	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	31.27	5.08	4.68	1.34	0.53	1.07	1.20	0.27	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	39.36	5.87	4.49	2.24	1.04	1.04	1.73	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	28.31	4.91	6.72	1.29	0.65	1.03	0.65	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	28.15	5.34	4.85	2.43	0.49	1.21	1.21	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	27.86	6.71	6.19	2.06	0.77	2.06	1.29	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	26.90	6.33	5.70	1.58	0.63	1.90	0.95	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	32.97	8.79	4.40	2.75	0.55	1.10	1.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	46.44	5.42	10.61	2.59	0.24	0.47	0.94	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	30.69	1.94	3.72	0.81	0.81	0.65	1.29	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	37.28	6.70	5.97	1.99	0.90	0.72	0.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	27.42	3.98	3.56	2.09	0.84	0.84	0.63	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	35.95	2.34	3.71	1.17	0.59	1.37	0.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	30.18	2.53	2.11	2.11	0.42	0.84	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	50.97	4.78	6.43	2.80	0.66	0.49	0.99	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	31.04	5.24	5.98	1.87	0.37	0.19	0.93	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	29.89	4.60	4.41	2.30	0.57	0.57	0.57	0.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	31.47	4.91	3.88	1.84	0.20	0.61	1.84	0.61	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	28.01	4.63	4.63	2.01	0.81	1.01	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	24.31	5.94	4.32	1.35	0.54	0.81	1.08	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	28.09	3.60	3.84	2.16	0.48	0.72	0.96	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	31.76	1.65	4.23	2.12	0.47	1.41	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	37.04	4.98	4.83	1.02	0.59	1.02	0.15	0.15	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	34.80	3.80	3.80	2.32	0.63	1.05	1.05	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	27.45	3.50	2.45	2.10	0.52	0.87	0.70	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	30.72	4.22	4.22	2.21	0.40	1.20	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	28.15	5.12	3.02	2.56	0.47	0.93	0.47	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	29.03	3.12	1.20	1.92	0.72	0.96	0.24	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	26.53	4.47	2.38	2.09	0.60	0.60	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	27.53	2.87	2.39	0.96	0.72	0.24	1.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	33.77	2.63	2.22	2.43	0.61	0.81	0.61	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	30.33	2.66	2.05	0.82	0.82	1.23	0.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	27.13	2.89	3.34	2.67	0.00	0.44	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	629.65	13.99	55.97	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	23.07	2.48	2.84	1.77	0.00	0.35	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	24.52	1.66	1.99	1.33	0.66	0.66	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	131.71	12.58	10.91	5.87	0.00	7.55	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	50.06	2.30	4.13	3.21	1.38	1.84	1.38	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	19.45	0.97	2.92	1.30	0.32	1.30	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	19.27	1.93	1.61	1.28	0.32	0.96	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	50.92	3.46	4.71	3.77	1.26	1.57	1.89	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	17.63	5.64	2.12	1.41	1.41	0.00	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	17.95	8.41	1.68	0.56	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	85.19	9.55	6.37	9.55	3.98	0.80	2.39	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	49.27	6.46	3.40	3.40	1.36	2.38	0.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	23.39	5.20	2.92	1.30	0.65	0.00	1.30	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	21.65	8.16	1.77	1.42	1.06	0.35	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	533.41	80.82	16.16	48.49	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	363.28	31.59	23.69	31.59	7.90	15.79	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	19.50	5.85	0.98	0.49	0.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	14.88	11.41	0.50	0.00	1.49	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.70	9.85	0.47	0.47	0.47	0.00	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	30.14	12.59	1.66	0.33	0.99	1.32	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	20.42	13.30	1.86	0.00	0.62	0.62	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	16.51	7.95	1.53	0.31	0.31	0.61	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	29.93	0.95	3.96	3.96	0.16	0.95	0.95	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	21.02	0.80	2.73	2.25	0.32	0.80	0.64	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	35.88	6.62	6.74	4.33	1.65	1.53	1.65	0.13	0.00
Adipocyte - omental, donor2	11474-119C7	22.42	1.49	1.49	1.49	0.00	2.24	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	24.45	2.01	2.01	4.69	0.00	1.34	0.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	23.61	2.55	3.19	1.91	0.64	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	0.00	0.00	1.10	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.52	1.81	1.81	0.90	0.00	0.90	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	17.38	1.22	0.70	0.87	0.00	1.39	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	40.29	17.01	5.87	4.11	1.37	0.98	1.17	0.59	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	16.73	5.40	2.83	2.57	0.77	0.26	1.03	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	30.11	26.20	3.90	3.90	1.12	0.84	0.84	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	25.86	13.52	5.88	5.88	1.18	2.35	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	40.22	7.80	3.70	3.54	0.80	1.05	1.21	0.32	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	21.95	9.68	1.94	4.84	0.65	0.65	1.29	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	18.13	10.13	3.20	2.13	2.13	0.53	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	25.60	5.01	3.90	3.90	0.56	2.23	0.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	18.30	3.33	2.91	4.57	0.00	0.83	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	18.34	5.53	2.26	2.51	0.50	1.00	0.25	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	21.93	4.91	1.96	1.96	0.00	2.29	0.33	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	13.40	7.00	3.96	2.13	1.22	0.61	0.61	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	9.94	2.21	0.22	0.88	0.00	0.66	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	2.87	0.72	0.00	0.00	0.00	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	17.09	3.06	0.72	0.18	0.18	0.90	0.00	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	10.27	1.85	0.41	0.00	0.41	0.41	0.00	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	32.95	11.44	3.43	2.17	0.69	1.49	0.46	0.00	0.23
Anulus Pulposus Cell, donor2	11463-119B5	23.76	1.71	1.96	1.96	0.24	1.47	0.24	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	25.16	3.15	1.35	0.45	0.45	1.80	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	22.14	5.21	1.74	0.87	0.87	1.74	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	2.14	0.00	2.14	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.92	3.89	0.60	0.00	0.30	0.90	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	16.44	3.79	2.53	0.00	0.00	2.53	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.88	3.30	0.66	0.00	0.66	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	14.94	3.57	0.97	0.65	0.00	2.27	0.00	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	14.56	4.37	0.49	0.49	0.49	0.00	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	20.79	6.53	0.59	0.00	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	22.22	6.78	2.26	0.38	0.38	1.51	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	24.67	5.08	0.00	0.00	0.73	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	1.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	19.60	5.11	1.15	0.99	0.33	0.82	0.00	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	21.84	2.73	1.36	0.00	0.00	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	17.49	6.48	1.36	0.60	0.75	0.15	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	18.75	2.14	0.54	0.54	1.61	1.61	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	14.74	3.21	0.94	0.19	0.19	0.38	0.57	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	17.64	4.28	0.80	1.34	0.53	0.80	0.00	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	18.53	5.85	0.00	0.00	0.00	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	17.75	1.66	1.49	0.17	1.00	1.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	3.60	1.20	0.00	0.00	2.40	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	7.08	7.08	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	24.01	2.74	1.20	1.03	0.69	0.51	0.34	0.34	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	16.50	3.88	0.49	0.97	0.49	1.46	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	20.49	6.07	1.52	1.14	0.38	0.76	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	2.42	1.21	0.00	1.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	14.25	1.71	1.14	0.57	0.57	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	19.24	3.21	0.43	0.86	0.21	1.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.87	2.32	1.29	0.52	0.52	0.52	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	19.24	0.94	0.00	0.00	0.00	1.88	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	16.40	2.57	0.64	0.64	0.00	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	20.69	1.43	0.71	0.00	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.89	2.34	1.17	0.00	0.00	1.75	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	17.46	3.91	0.60	0.30	0.30	1.81	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	13.07	5.94	0.00	0.00	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	23.90	6.10	0.51	0.00	1.53	1.02	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	22.67	5.86	0.51	0.51	0.00	1.02	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.88	1.91	0.00	0.64	1.27	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	22.01	2.16	0.43	1.29	0.00	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	16.72	5.72	1.27	0.42	0.85	0.42	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	15.66	2.03	0.87	0.58	0.00	0.00	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	26.45	3.78	0.00	0.94	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	18.65	4.24	1.19	0.68	0.34	1.36	0.00	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	2.32	0.00	2.32	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	2.11	0.00	2.11	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	15.65	2.79	1.07	0.64	0.86	0.21	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	13.84	4.21	1.80	1.20	0.60	1.80	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	18.95	5.10	2.19	0.73	1.46	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	21.38	3.45	0.23	0.00	0.46	0.92	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	7.65	0.00	0.00	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	22.37	3.31	1.78	1.02	0.25	0.76	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.75	2.48	1.24	0.41	0.41	1.65	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	18.05	4.59	0.61	0.31	0.61	0.61	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	21.51	4.78	1.43	1.91	0.48	0.96	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	18.85	3.99	0.89	0.44	0.22	1.77	0.44	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	6.10	3.05	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	18.28	4.98	1.66	0.00	0.55	0.55	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	19.07	4.77	1.06	1.06	0.79	0.26	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	18.90	4.72	1.09	0.36	0.00	1.09	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	13.88	4.05	0.74	0.74	0.61	1.35	0.61	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	8.04	1.88	0.00	0.17	0.17	0.86	0.17	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	6.71	2.31	0.21	0.00	0.42	0.21	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	46.71	27.19	1.39	1.74	3.14	3.49	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	40.44	12.29	0.81	0.81	1.46	4.85	0.49	0.32	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	38.63	8.20	0.45	0.15	0.45	2.39	0.30	0.00	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	41.40	2.52	0.00	0.23	0.57	2.06	0.11	0.00	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	32.57	3.26	0.25	0.38	0.13	1.88	0.00	0.00	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	35.16	3.07	0.00	0.68	0.23	1.25	0.00	0.11	0.00
Basophils, donor1	12241-129G9	48.12	43.15	0.78	2.35	0.78	0.78	0.26	0.26	0.00
Basophils, donor2	12242-129H1	49.07	24.17	0.72	3.25	4.69	2.53	0.00	0.00	0.36
Basophils, donor3	12243-129H2	29.84	9.11	0.88	1.62	0.44	0.88	0.15	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	6.90	1.72	0.43	0.00	0.22	0.65	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.20	0.46	0.00	0.00	0.00	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.90	0.63	0.63	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	3.12	0.62	0.42	0.42	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	9.21	5.99	0.69	0.23	0.46	0.23	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	16.55	4.86	1.08	0.36	0.18	1.98	0.72	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	60.70	1.03	0.41	1.34	0.10	3.71	0.10	0.00	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	83.61	6.06	0.70	4.89	0.00	5.36	0.23	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	23.66	3.52	0.00	1.28	0.64	1.28	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	20.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	60.86	3.94	0.56	5.64	0.00	1.69	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	27.65	2.78	0.19	1.86	0.37	1.11	0.19	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	35.13	3.73	1.32	1.54	0.00	0.22	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	66.52	0.28	5.38	3.96	0.00	3.40	1.13	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	58.76	0.00	5.69	3.41	0.00	3.79	1.52	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	82.84	0.00	7.23	4.93	0.33	4.93	1.64	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	31.95	8.24	3.32	4.05	0.29	0.87	1.30	0.29	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	26.86	3.92	2.41	7.85	1.51	0.30	1.21	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	31.98	7.11	4.74	3.55	0.24	0.95	0.71	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	18.75	7.53	1.34	3.52	0.33	1.00	0.17	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	23.46	6.07	2.21	3.86	0.55	0.00	0.55	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	22.81	5.95	1.49	4.21	0.74	0.25	0.50	1.24	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	28.98	1.76	1.57	4.31	0.20	0.98	0.78	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	31.51	6.59	2.14	4.63	0.18	0.36	0.53	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	41.13	8.27	2.83	6.31	0.44	1.74	0.65	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	19.67	11.71	1.40	3.04	0.23	1.40	0.70	0.47	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	20.07	10.03	1.06	3.70	1.06	0.53	1.58	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	22.19	14.42	4.44	3.33	0.00	0.00	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	22.91	6.40	2.38	4.02	0.30	0.30	0.59	0.15	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	28.54	7.98	4.19	6.98	0.60	0.80	1.20	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	37.48	7.50	5.00	7.29	0.42	0.62	1.87	0.62	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	29.51	12.13	1.83	6.18	1.37	0.92	1.14	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	28.73	14.93	2.94	11.31	0.90	0.45	0.45	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	29.24	11.78	3.93	8.29	0.44	2.18	1.75	2.18	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	23.40	2.42	1.88	6.19	0.54	0.54	0.81	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	36.29	6.46	2.79	8.72	0.17	0.52	1.05	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	34.09	6.73	2.95	4.63	0.42	2.52	0.42	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	17.45	10.29	0.37	1.84	0.92	0.73	0.73	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	16.91	9.86	1.06	3.52	2.11	0.35	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	17.55	7.02	0.88	0.44	0.44	0.88	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	27.03	4.18	2.27	5.58	0.52	0.52	0.87	0.52	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	29.73	3.72	2.97	7.43	0.74	0.00	0.37	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	37.94	6.25	2.59	9.27	0.43	0.22	0.43	0.86	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	14.74	9.83	1.23	2.87	0.82	0.82	0.41	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	16.69	11.82	2.32	2.78	0.70	0.70	0.00	0.93	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	18.79	13.92	0.93	4.18	0.46	0.23	0.00	1.62	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	24.63	0.44	0.65	1.09	0.00	1.31	0.22	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	27.49	1.15	0.23	1.39	0.00	1.15	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	25.13	0.65	0.65	1.73	0.00	0.43	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	39.86	1.56	0.78	2.49	0.00	0.93	0.93	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	24.45	0.70	0.52	1.57	0.00	1.05	0.17	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	29.21	2.01	0.45	3.34	0.00	1.78	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	22.71	2.30	0.77	1.53	0.00	1.53	0.26	0.77	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	23.27	1.32	0.22	0.66	0.00	0.44	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	26.74	1.68	0.21	1.05	0.00	1.05	0.00	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	54.87	8.13	0.00	0.00	0.00	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	62.37	6.78	0.68	0.00	0.68	1.36	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	41.42	1.04	1.04	1.04	0.00	2.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	62.90	6.40	0.00	1.07	0.53	2.67	0.53	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	59.50	2.68	0.00	1.07	0.54	1.61	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	57.56	6.32	0.00	0.70	2.81	2.11	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	48.63	5.49	0.00	1.57	0.00	0.78	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	61.96	1.32	0.00	0.00	0.00	6.59	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	49.31	26.30	0.00	2.47	1.64	2.47	0.00	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	34.82	26.12	0.00	1.45	2.90	0.73	0.00	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	42.41	18.17	1.01	4.04	1.51	1.01	0.50	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	229.10	418.20	0.00	2.02	98.19	6.46	0.40	29.09	2.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	161.79	318.79	2.80	3.20	83.49	8.39	0.80	19.58	2.00
CD34+ Progenitors, donor1	11545-120B6	8.03	9.04	0.00	0.00	2.01	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	9.55	11.80	0.56	0.56	1.12	0.56	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	16.91	3.38	0.38	0.00	0.00	1.88	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	23.22	2.93	0.00	0.00	0.00	1.58	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	30.71	5.36	0.36	0.00	0.00	0.71	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	26.33	3.06	0.00	0.61	0.00	1.22	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	27.75	4.57	0.00	1.22	0.00	1.22	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	68.15	1.02	0.26	2.55	0.00	3.32	0.51	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	56.15	0.22	0.45	0.67	0.00	3.14	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	53.47	0.86	0.00	1.72	0.00	1.15	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	42.19	4.74	0.47	0.00	0.00	1.42	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	54.08	6.32	0.00	0.70	0.00	1.40	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	3.30	0.00	0.00	3.30	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	57.08	4.34	0.29	2.17	0.58	3.03	0.43	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	38.30	1.53	0.17	1.86	0.00	1.36	0.00	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	43.53	0.97	0.16	1.77	0.16	1.13	0.16	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	38.11	7.62	0.45	0.45	0.00	0.90	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	34.24	3.14	0.00	0.35	0.00	1.40	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	44.88	5.28	0.00	0.00	0.44	1.76	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	53.13	1.69	0.42	2.11	0.00	5.90	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	35.74	2.49	0.42	0.62	0.21	1.04	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	33.08	2.34	0.00	1.00	0.00	1.67	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	48.13	6.25	0.54	0.54	0.27	1.63	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	65.39	4.82	0.00	0.00	0.00	2.14	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	34.07	1.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	68.24	0.56	0.37	1.11	0.00	3.52	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	51.12	1.08	0.22	1.08	0.00	1.30	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	47.28	0.00	0.00	1.05	0.00	2.31	0.21	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	43.99	3.03	0.00	0.51	0.00	1.52	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	26.43	3.47	0.00	0.87	0.00	2.17	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	50.55	0.44	0.00	1.74	0.00	2.61	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	72.25	0.49	0.00	0.49	0.00	3.46	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	79.39	0.00	0.00	0.00	0.00	2.77	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	60.02	0.00	0.00	1.40	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	91.39	0.83	0.00	2.22	0.00	4.98	0.28	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	113.13	0.25	0.00	1.23	0.25	4.91	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	60.06	0.00	0.00	1.54	0.00	3.08	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	75.56	1.79	0.00	1.79	0.00	4.30	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	70.63	0.00	0.00	0.00	0.00	2.77	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	46.16	6.88	0.65	1.64	0.00	1.31	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	28.53	3.38	0.00	0.00	0.00	0.75	0.75	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	31.56	3.53	0.76	0.76	0.00	0.50	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.70	2.52	0.23	0.46	0.23	0.23	0.23	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.26	3.59	0.24	0.00	0.00	0.48	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	10.40	3.56	0.27	1.09	0.00	0.27	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	13.51	5.10	0.90	0.90	0.30	0.00	0.30	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	10.56	3.60	0.00	0.24	0.24	0.24	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.91	3.41	0.23	0.68	0.23	0.45	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	10.43	3.48	0.22	0.43	0.00	0.22	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	16.58	3.16	0.00	0.53	0.00	0.79	0.00	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	14.31	2.35	0.23	0.70	0.23	0.94	0.23	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	15.40	4.23	0.60	0.00	0.00	0.30	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	14.23	3.49	0.58	0.58	0.58	0.29	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	16.25	2.13	0.00	0.53	0.27	0.80	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	14.88	6.13	1.31	1.31	0.44	0.88	1.31	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	15.48	4.55	0.91	0.91	0.46	0.91	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	9.70	4.48	2.98	1.49	0.00	0.75	0.00	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	8.28	4.68	0.00	0.72	0.72	0.36	0.00	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	7.77	2.01	0.29	0.29	0.29	0.58	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	7.31	2.83	0.24	1.41	0.00	0.00	0.24	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	13.31	2.85	0.32	0.32	0.32	0.00	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	10.46	1.54	0.92	0.92	0.00	0.62	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	11.54	3.85	0.32	0.00	0.00	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	16.06	8.03	0.00	0.38	0.00	0.76	0.38	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.85	2.36	0.39	0.79	0.79	0.79	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	14.37	2.27	0.00	0.76	0.00	0.76	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	46.57	18.47	1.61	5.62	0.80	4.01	1.61	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	36.37	18.88	2.80	6.29	0.00	1.40	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	39.07	11.02	4.01	8.01	2.00	2.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	9.14	21.93	3.66	0.00	0.00	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	13.34	6.92	1.98	0.49	0.00	0.00	0.99	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	21.78	6.00	0.53	1.05	1.16	0.63	0.32	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	19.41	5.89	5.89	3.47	1.04	0.69	2.08	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	7.11	1.07	1.42	1.07	1.07	0.71	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	12.40	0.68	1.93	0.91	0.34	0.00	0.46	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	31.33	3.58	5.37	2.69	0.00	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	15.77	0.81	0.00	0.00	0.00	1.21	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	49.58	21.57	3.21	1.26	3.56	3.79	0.46	0.23	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	24.16	10.47	1.71	0.86	0.64	1.28	0.21	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	29.65	6.55	2.83	0.44	0.80	1.06	0.62	0.18	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	41.72	34.85	8.53	4.40	4.59	2.66	2.38	0.18	0.55
Corneal Epithelial Cells, donor1	11526-119I5	3.95	0.22	0.22	0.00	0.00	0.00	0.00	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	9.10	3.41	4.55	1.14	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	2.81	0.26	1.53	0.26	0.26	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	28.07	0.66	3.96	2.81	0.00	1.65	0.66	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	31.54	0.63	4.42	1.26	0.32	1.26	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	0.00	6.90	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	19.55	0.11	2.16	1.30	0.22	0.54	0.43	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	28.01	2.05	0.68	1.37	0.00	0.68	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	29.38	1.96	0.00	1.31	0.00	1.31	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	27.10	2.42	0.97	1.45	0.00	1.45	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	13.51	3.50	3.17	3.67	0.83	0.50	0.67	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	4.11	0.59	1.76	0.00	0.00	0.00	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	7.92	1.41	2.83	3.39	0.00	0.28	0.57	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	11.40	0.79	1.97	1.97	0.00	0.00	1.18	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	8.44	0.87	1.45	2.91	0.00	0.58	2.62	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	19.53	2.82	0.47	3.29	0.00	0.94	0.47	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	8.41	1.58	1.40	1.40	0.18	0.35	1.05	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	31.47	1.55	10.20	6.87	0.44	1.55	2.88	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	41.99	2.43	7.91	7.91	0.00	1.83	3.35	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	45.10	1.13	15.50	14.94	0.28	1.97	5.92	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	8.62	0.59	9.21	5.05	0.30	0.00	1.49	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	7.81	2.08	7.81	5.73	0.00	0.00	3.12	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	4.40	0.00	4.40	3.26	0.00	0.28	0.85	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	21.21	2.40	8.40	8.40	1.60	0.80	2.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	12.58	1.05	2.10	0.52	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	42.49	13.67	10.56	11.80	1.37	1.62	3.11	0.12	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	19.12	1.96	4.35	6.30	0.00	1.09	2.61	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	18.81	2.69	2.93	3.54	0.37	1.10	1.34	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	7.96	0.00	0.00	1.14	0.00	0.00	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	9.78	1.40	0.70	0.70	0.00	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	13.50	0.94	2.04	2.67	0.16	0.00	0.79	0.00	0.00
Eosinophils, donor1	12244-129H3	0.00	45.74	0.00	15.25	60.99	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	95.72	13.20	3.30	11.55	0.00	1.65	1.65	1.65	0.00
Eosinophils, donor3	12246-129H5	92.74	21.40	0.00	7.13	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	5.86	1.47	0.24	0.24	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	4.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	24.22	4.93	4.52	3.28	0.41	1.23	0.82	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.48	1.86	1.09	0.44	0.22	0.44	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	4.98	1.08	0.54	0.43	0.11	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	24.86	6.19	2.79	2.18	1.21	1.33	1.09	0.00	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	40.40	4.78	2.32	2.32	0.82	0.96	1.09	0.68	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	15.50	4.01	0.63	1.16	0.74	0.11	0.21	0.00	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	45.85	23.45	7.90	5.53	3.69	1.58	0.79	0.53	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	20.93	3.65	1.66	0.66	0.33	1.33	0.33	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	10.89	3.63	0.45	1.36	0.45	0.45	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	6.82	1.52	0.00	0.76	0.76	0.00	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	12.78	5.36	0.32	1.10	0.95	0.32	0.47	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	51.53	16.37	5.15	3.33	1.82	1.21	1.21	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	33.12	9.52	3.81	1.90	0.76	1.14	1.02	0.13	0.25
Fibroblast - Cardiac, donor6	11460-119B2	27.29	3.64	2.43	1.82	0.61	0.76	0.45	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	24.39	3.22	1.21	1.61	0.40	1.34	0.40	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.43	4.75	1.29	1.73	0.43	1.29	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	5.86	0.00	0.00	2.93	2.93	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	8.53	14.07	0.23	0.69	0.92	1.38	0.00	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	40.20	10.18	5.09	1.70	1.19	2.20	0.85	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	32.17	2.58	1.41	0.70	0.23	1.17	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	11.79	1.42	1.42	0.47	0.00	0.94	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	22.61	2.66	1.45	0.36	0.24	0.48	0.24	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	30.18	12.77	1.02	0.11	1.02	1.47	0.00	0.23	0.11
Fibroblast - Dermal, donor5	11454-119A5	30.01	10.99	0.87	0.17	1.22	2.44	0.17	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	35.57	6.66	0.65	0.81	0.65	1.62	0.16	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	57.26	5.62	2.50	3.54	0.83	2.50	0.21	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	24.37	4.98	3.93	1.57	0.26	0.00	0.79	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	34.92	2.50	0.66	0.79	0.79	1.84	0.00	0.00	0.13
Fibroblast - Gingival, donor3	11394-118C8	43.99	7.35	1.74	1.16	0.77	1.35	0.29	0.10	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	18.70	4.16	2.08	1.04	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	10.92	3.00	1.06	0.88	0.53	0.00	0.18	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	23.54	3.90	1.40	1.56	0.31	0.62	0.78	0.00	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	21.23	3.11	2.43	2.03	0.54	0.95	0.27	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	6.35	1.06	0.71	0.00	0.00	0.71	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	22.52	4.53	1.90	2.05	0.44	0.58	0.29	0.15	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	25.50	2.86	2.73	0.95	0.41	1.09	0.41	0.27	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	21.39	4.28	1.86	2.08	0.88	0.55	0.33	0.00	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	26.41	2.79	1.47	2.20	0.88	1.32	0.29	0.00	0.15
Fibroblast - Lung, donor1	11270-116H1	8.16	4.08	1.36	2.72	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	32.83	8.95	4.48	1.49	5.97	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	21.31	4.01	1.06	0.42	0.21	0.63	0.21	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	7.50	2.50	0.83	0.00	1.67	0.00	0.00	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	0.00	0.00	2.80	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.96	1.12	0.00	0.00	0.00	0.00	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	19.89	2.44	0.41	0.41	0.00	0.81	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	36.27	6.01	0.58	1.16	0.58	2.52	0.39	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	42.32	5.16	0.76	0.61	0.91	2.43	0.00	0.15	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	64.26	5.20	1.53	1.84	0.92	1.84	1.22	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	16.41	2.29	3.82	1.53	1.14	0.38	0.76	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	14.31	2.97	0.81	0.81	0.81	0.54	0.81	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	12.87	1.62	1.62	1.62	0.12	0.46	0.35	0.23	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	25.42	4.86	1.33	1.77	0.22	0.22	0.44	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	20.32	2.84	0.61	1.63	1.02	1.02	0.41	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	18.71	1.34	0.67	0.67	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.19	2.77	1.19	0.40	0.00	1.19	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	35.13	3.97	1.79	1.39	0.60	2.58	0.20	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	30.55	1.95	1.42	0.89	0.36	1.60	0.00	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	27.59	1.77	0.39	0.59	1.77	1.97	0.39	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	27.98	5.42	1.20	0.60	1.50	0.60	0.90	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	30.87	4.64	1.19	1.19	0.97	1.73	0.54	0.11	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	23.03	5.57	1.77	1.52	1.27	0.76	0.00	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	24.28	3.45	1.31	1.80	1.31	1.15	0.00	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	51.13	10.63	4.81	4.41	1.80	1.20	1.40	0.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	37.27	6.03	2.11	2.41	0.90	1.61	0.30	0.00	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	25.69	6.95	3.02	1.21	0.91	1.21	1.51	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	29.16	3.65	1.24	2.24	0.66	1.16	0.58	0.08	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	40.52	7.01	6.67	4.27	1.71	1.37	0.85	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	46.64	7.88	2.96	3.28	1.31	1.97	1.64	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	35.26	4.58	2.24	2.13	0.64	1.81	1.07	0.11	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	17.21	3.04	0.34	0.34	0.34	1.01	0.17	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	26.82	5.18	1.57	0.63	0.78	0.94	0.16	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	288.08	44.32	66.48	22.16	22.16	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	40.96	74.08	20.92	6.97	6.10	2.61	5.23	1.74	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	27.56	0.69	1.91	1.04	0.00	1.56	0.69	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	34.87	3.64	0.78	0.78	0.26	0.78	0.52	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	23.25	0.77	0.77	2.04	0.26	0.77	0.51	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	18.37	0.77	0.77	0.77	0.00	1.53	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	17.87	1.28	0.64	1.28	0.64	0.64	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	57.05	4.56	0.57	1.71	0.29	3.14	1.14	0.29	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	45.22	12.13	1.93	2.76	3.31	8.27	1.38	0.28	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	27.40	24.20	3.20	4.79	2.51	2.51	2.74	0.46	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	39.63	7.13	0.40	1.39	1.39	3.17	0.40	0.20	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	40.44	10.04	1.59	1.85	2.11	4.49	1.06	0.53	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	31.64	23.16	3.59	4.24	3.59	2.94	1.30	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	48.20	10.61	0.00	0.88	0.00	0.88	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	30.24	3.25	0.42	1.27	0.14	3.11	0.00	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	27.95	5.79	0.99	1.35	1.35	2.59	0.12	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	17.19	1.07	1.61	0.54	0.54	0.81	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	27.63	3.22	0.62	1.24	0.87	3.10	0.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	24.50	4.29	0.28	0.69	0.55	3.05	0.14	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	26.43	4.07	0.41	0.61	1.02	1.02	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	26.24	5.70	0.23	0.68	1.14	2.51	0.46	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	26.78	2.99	0.75	0.87	0.75	2.62	0.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	27.76	3.28	0.66	0.66	0.44	1.31	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	27.48	5.32	0.89	1.48	1.48	1.48	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	32.59	6.20	0.79	1.11	0.95	4.61	0.16	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	29.04	4.92	0.67	0.89	0.45	0.89	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	31.05	5.65	0.40	0.40	0.81	3.23	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	34.44	9.33	0.51	0.85	1.02	4.24	0.17	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	38.93	11.44	1.68	2.13	1.60	1.77	0.18	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	49.63	10.82	0.42	0.31	1.77	4.47	0.31	0.00	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	44.57	9.56	0.17	0.85	1.02	3.93	0.00	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	30.54	7.75	0.22	0.77	1.66	3.98	0.22	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	38.77	12.23	0.75	1.66	0.83	3.16	0.08	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	33.08	13.88	0.82	1.63	1.84	2.86	0.00	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	34.04	9.49	0.83	0.00	1.24	3.09	0.00	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	35.40	6.23	0.35	0.46	1.04	4.27	0.23	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	33.69	8.17	0.50	0.50	1.00	1.83	0.17	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	29.54	6.17	0.44	0.00	0.66	1.76	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	38.99	10.70	0.61	0.25	1.60	4.30	0.37	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	32.42	11.99	0.49	0.65	1.46	1.78	0.00	0.49	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	38.81	8.34	0.64	0.32	2.25	3.53	0.00	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	27.95	9.19	0.28	0.28	1.33	2.75	0.00	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	27.21	5.06	0.16	0.63	0.95	2.69	0.00	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	31.93	14.90	0.00	1.52	5.17	3.04	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	33.35	9.20	0.21	0.63	2.09	3.35	0.42	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	29.86	8.34	0.88	0.22	1.32	2.20	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	32.26	18.52	0.00	1.12	1.68	2.81	0.00	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	30.18	12.87	0.46	1.39	1.30	2.31	0.37	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	32.36	17.38	1.07	2.94	2.41	1.34	0.27	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	29.38	14.69	1.53	1.68	1.22	1.53	0.15	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	23.96	8.81	0.52	1.17	1.55	3.37	0.00	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	31.72	9.22	0.81	1.08	1.90	2.44	0.54	1.08	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	32.26	10.14	0.55	0.18	1.29	1.11	0.18	0.37	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	34.43	10.75	0.22	0.88	0.88	3.07	0.00	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	45.62	9.92	0.00	3.97	1.98	5.95	0.99	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	30.47	6.73	1.06	0.26	0.26	1.19	0.40	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	27.44	8.47	0.81	0.40	0.61	2.02	0.00	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	75.49	25.92	1.27	2.03	3.81	3.56	0.25	1.52	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	46.38	1.99	0.80	1.19	0.40	4.18	0.40	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	30.51	1.54	0.46	0.62	0.00	2.47	0.15	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	33.35	1.64	0.20	1.02	0.20	3.68	0.20	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	22.84	2.82	0.31	0.31	0.00	1.56	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	23.73	2.54	0.28	1.13	0.28	1.41	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	34.13	1.38	0.00	1.38	0.92	6.92	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	42.07	9.90	0.00	0.00	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	23.60	6.58	0.39	1.55	1.55	1.16	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	0.00	1.60	8.02	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	34.78	3.48	1.74	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	28.64	3.91	0.98	1.30	0.65	0.65	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	40.36	7.00	1.65	1.24	1.24	2.88	0.82	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	13.33	3.33	3.33	0.00	6.66	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	33.56	6.99	0.84	1.96	0.84	2.80	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	28.44	7.52	0.33	1.96	0.65	3.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	40.26	3.36	1.68	0.84	1.68	4.19	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	37.21	5.09	0.95	2.23	0.32	2.86	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	33.63	7.47	1.36	1.02	1.02	1.70	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	50.12	4.18	2.09	0.00	2.09	6.26	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	24.05	8.02	1.15	1.72	0.00	2.29	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	16.28	3.55	1.78	0.30	0.30	2.37	0.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	27.11	5.08	3.39	0.00	0.00	0.00	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	31.07	4.56	2.90	2.49	0.00	2.07	1.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	28.77	7.82	2.07	2.07	1.15	2.07	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	21.14	3.84	1.15	1.92	1.15	3.46	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	27.71	9.45	0.65	1.96	1.30	2.61	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	20.73	5.35	0.00	0.67	0.67	2.68	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	32.75	3.47	0.00	0.39	1.16	4.24	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	27.04	6.85	1.03	1.71	1.03	2.40	0.00	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	64.60	14.91	0.00	0.00	2.48	4.97	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	38.22	11.32	0.47	0.47	1.89	0.94	0.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	24.74	2.41	1.21	0.00	0.60	3.62	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	34.08	8.65	1.53	3.56	0.51	2.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	43.47	5.58	0.80	0.00	0.40	3.59	0.00	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	41.94	8.88	0.99	1.48	4.44	2.96	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	42.50	18.89	0.00	2.36	1.18	8.26	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	27.42	8.75	0.00	1.17	2.33	4.08	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	43.45	7.46	0.44	0.44	1.32	7.46	0.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.04	15.26	0.85	0.85	2.54	3.39	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	19.10	6.57	0.00	1.19	1.79	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	26.69	7.28	0.97	2.91	0.00	0.49	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	12.55	0.00	1.14	1.14	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.98	0.42	1.25	0.42	0.00	0.83	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	13.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	21.88	0.32	0.95	0.32	0.00	1.90	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	21.72	0.84	0.42	0.42	0.00	1.25	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	10.33	5.80	1.62	0.93	0.81	0.12	0.12	0.23	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	11.82	7.26	0.84	1.18	0.34	1.01	0.34	0.84	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	10.69	5.46	0.46	1.14	0.46	0.68	0.46	0.68	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	10.82	7.11	0.66	1.42	0.22	0.22	0.66	0.22	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	10.75	6.45	0.86	1.50	0.43	1.07	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	11.41	7.53	1.29	0.86	0.43	0.00	0.22	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	9.59	5.98	0.75	1.25	0.25	0.25	0.12	0.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	8.23	5.83	0.86	1.89	0.86	0.34	0.00	0.51	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	9.93	5.13	0.00	1.92	0.64	0.00	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	11.75	1.12	1.68	2.24	0.00	0.00	1.68	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	2.60	0.43	0.87	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	5.29	15.86	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	13.40	2.82	0.00	0.35	0.35	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	0.00	0.00	0.00	0.73	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	16.26	7.69	1.75	1.22	0.87	0.52	0.87	0.00	0.00
Hepatocyte, donor1	11523-119I2	12.11	2.42	3.63	4.84	0.00	1.21	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	18.31	0.00	0.00	1.08	0.00	0.00	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	32.52	3.68	6.75	9.82	0.00	0.61	4.29	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	26.11	0.65	0.00	0.65	0.00	1.96	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	35.66	6.29	0.35	0.52	0.87	1.40	0.00	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	29.09	7.55	1.23	1.51	0.96	1.10	0.69	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	15.92	0.00	0.00	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	13.35	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	11.08	4.15	0.00	0.00	0.00	0.00	0.00	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	15.02	0.00	0.00	5.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00	0.00	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	9.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	17.87	4.87	0.00	1.62	1.62	1.62	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	11.67	5.00	0.00	0.00	3.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	10.89	0.00	0.00	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	17.21	3.97	0.00	0.00	0.00	0.00	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	7.76	0.00	0.00	2.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	15.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	10.08	10.71	0.00	0.00	3.78	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	7.73	3.09	0.00	0.00	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	29.27	0.00	14.63	0.00	0.00	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	8.40	9.69	0.65	0.65	0.65	1.94	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	9.66	0.00	0.00	1.61	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	10.59	5.70	0.00	0.00	2.44	1.63	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	8.40	6.30	0.00	0.42	0.84	1.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	5.63	16.07	0.00	0.00	3.21	0.00	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	17.54	0.00	0.00	1.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00	0.00	0.00	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	7.08	7.08	0.00	0.00	0.94	0.00	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	4.53	2.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	0.00	0.00	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	7.53	7.53	1.08	0.00	2.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	7.62	7.62	0.00	0.00	3.81	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	15.94	7.65	0.00	0.00	0.00	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	1.82	0.00	0.00	5.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	16.42	10.00	0.00	0.00	1.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	3.32	0.00	0.00	0.00	0.00	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	6.79	7.72	0.00	0.31	1.54	0.31	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	0.00	0.00	0.00	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	3.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	11.13	6.26	0.00	0.70	1.39	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	11.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	5.23	2.62	0.00	0.00	1.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	6.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	10.45	0.00	0.00	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	11.73	14.93	0.00	0.00	0.00	1.07	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	6.93	13.85	0.00	0.00	1.39	1.39	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	5.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	2.76	0.00	0.00	1.84	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	6.05	0.00	0.00	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	6.21	0.00	0.00	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	5.29	7.40	0.00	1.06	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	17.14	1.96	1.63	0.82	0.16	0.57	0.57	0.33	0.00
Keratinocyte - epidermal, donor2	11349-117G8	2.93	4.69	0.59	0.00	1.17	0.59	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	15.90	1.33	0.76	0.66	0.19	0.76	0.28	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	39.16	4.99	1.93	1.02	1.02	3.52	0.34	0.00	0.11
Keratocytes, donor1	11527-119I6	11.00	13.75	0.00	0.69	1.38	1.38	0.00	0.34	0.00
Keratocytes, donor2	11607-120I5	3.52	1.17	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	19.96	15.02	0.20	0.40	1.78	1.19	0.00	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	19.78	15.39	0.00	2.20	0.00	0.00	2.20	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	8.63	6.47	2.16	0.00	1.08	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	48.09	11.88	1.61	1.15	4.15	4.73	0.35	0.58	0.23
Lens Epithelial Cells, donor3	11690-122I7	34.81	8.58	0.71	1.51	2.22	2.02	0.40	0.10	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	13.64	3.44	10.20	5.93	0.36	0.36	2.96	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.81	1.67	3.35	3.07	0.28	0.28	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	16.37	4.72	20.15	10.70	0.16	0.47	4.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.60	2.69	6.99	3.23	0.00	0.00	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.73	0.95	2.84	1.26	0.32	0.00	0.95	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.58	1.62	6.47	3.45	0.00	0.11	1.29	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	11.90	2.46	8.62	3.69	0.00	0.41	2.05	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.79	1.26	1.77	2.28	0.00	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.57	0.70	4.64	3.66	0.00	0.14	1.55	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	10.28	3.56	3.16	4.75	0.00	0.40	1.98	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.50	2.13	1.94	4.07	0.58	0.39	0.78	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.70	1.67	1.48	2.22	0.00	0.00	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	7.32	2.79	4.53	4.88	0.35	0.70	1.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	7.63	1.67	4.53	2.86	0.00	0.24	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.77	1.24	4.67	3.57	0.00	0.27	1.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	10.78	1.85	4.93	4.62	0.62	0.31	0.92	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.36	1.56	2.18	0.31	0.00	0.31	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	4.76	0.91	5.67	3.66	0.00	0.37	0.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7.24	0.66	8.23	3.95	0.33	0.00	1.32	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.39	1.76	2.05	0.88	0.59	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.97	0.50	4.48	2.49	0.25	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.24	1.45	5.33	4.36	0.48	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	10.50	4.58	3.50	2.96	0.54	0.00	1.35	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	5.15	1.97	9.23	5.15	0.61	0.00	2.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.33	3.63	4.67	3.11	0.52	0.52	3.11	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	9.84	2.30	4.82	2.93	0.84	0.21	1.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.07	1.50	6.47	4.06	0.45	0.00	1.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	10.32	0.69	7.57	4.82	0.69	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.40	1.13	2.82	3.01	0.00	0.19	1.13	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.98	1.17	4.14	2.01	0.11	0.11	0.95	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.24	3.39	9.21	3.39	0.48	0.00	1.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3.97	1.98	3.31	2.98	0.00	0.66	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.20	1.98	5.70	2.97	0.00	0.00	1.86	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	16.29	4.44	12.59	8.51	1.11	0.00	3.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.19	2.22	1.98	1.24	0.49	0.25	0.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.16	1.37	2.47	1.24	0.14	0.00	0.55	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	13.83	1.61	5.47	4.18	0.32	0.64	0.96	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	9.43	5.17	5.48	3.65	0.61	0.00	1.52	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.82	2.24	9.80	6.02	0.70	0.00	1.54	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	9.96	2.84	8.53	2.13	0.36	0.36	1.78	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.85	0.97	1.94	1.45	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.96	1.24	2.65	2.33	0.00	0.00	0.62	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	9.31	2.15	4.30	3.22	0.00	0.36	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	4.25	0.98	1.63	2.29	0.00	0.33	0.98	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	5.89	0.94	1.88	2.59	0.24	0.00	1.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	15.96	3.22	10.52	4.95	0.00	0.25	3.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2.05	2.05	1.02	1.02	0.26	0.51	0.77	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.56	0.60	5.67	3.28	0.00	0.30	1.79	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	10.74	0.77	1.53	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.20	0.74	0.74	1.48	0.00	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	11.85	0.00	0.42	0.85	0.00	1.27	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.03	0.70	1.41	0.70	0.00	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	0.00	0.00	0.93	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	7.21	1.03	0.00	2.06	0.52	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	7.14	0.00	1.19	2.38	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	12.67	0.68	1.13	0.68	0.00	0.68	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	6.98	0.58	1.45	0.58	0.87	0.58	0.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	13.96	0.90	0.00	0.90	0.00	0.45	0.90	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	13.41	0.54	1.76	1.22	0.00	0.41	0.14	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	5.14	0.51	1.54	0.51	0.51	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	9.17	0.35	0.35	0.71	0.00	0.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	11.33	0.67	0.67	1.33	0.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	9.17	1.02	1.02	1.02	0.00	1.02	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	13.61	0.27	1.33	0.53	0.53	0.53	0.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	13.04	0.94	0.94	0.94	0.00	0.76	0.38	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	8.59	0.61	1.23	1.23	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	12.23	0.82	0.00	2.45	0.00	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	9.16	1.25	2.08	1.67	0.00	0.42	0.62	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	11.77	1.40	2.80	2.24	0.00	1.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	4.12	3.09	2.06	1.03	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	9.58	0.29	1.74	1.45	0.00	0.29	0.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.16	0.60	2.39	1.20	0.30	0.30	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	14.94	0.55	0.00	1.66	0.00	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	11.31	1.06	0.71	1.77	0.71	0.00	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	8.85	0.37	0.74	1.11	0.00	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	0.00	1.15	1.15	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.06	0.38	1.54	0.38	0.00	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.32	0.00	1.70	2.26	0.00	1.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	10.67	0.82	0.00	1.64	0.00	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.94	0.45	0.00	1.36	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	8.62	0.72	0.00	0.72	0.00	0.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	0.00	2.24	0.00	0.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	8.55	1.11	0.37	0.37	0.00	0.00	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	8.18	0.00	0.86	1.72	0.00	0.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	10.28	0.00	2.57	2.57	0.00	0.00	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	8.66	1.33	0.67	1.00	0.00	1.33	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	11.46	0.60	1.21	1.21	0.00	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.82	0.71	2.13	0.71	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	6.87	0.69	0.34	1.03	0.00	0.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.98	1.07	0.00	0.54	0.00	1.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.73	0.67	0.67	2.69	0.00	1.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	11.11	0.74	0.74	1.11	0.37	0.37	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	15.12	0.00	0.00	1.16	0.00	0.00	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6.35	2.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	11.20	0.40	0.00	1.60	0.40	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.18	0.73	0.73	1.45	0.00	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	9.96	0.00	0.00	1.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	9.87	0.00	1.97	0.49	0.00	0.00	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	8.47	0.94	1.88	0.00	0.00	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	8.05	1.01	1.01	0.00	0.00	0.00	0.00	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	9.46	0.90	1.35	0.90	0.90	0.90	0.90	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	5.16	0.00	0.00	1.72	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	8.91	1.34	1.34	2.23	0.00	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	10.95	0.00	0.78	1.56	0.39	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	6.60	0.00	0.66	1.98	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	7.26	1.04	0.00	0.52	0.00	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	7.44	1.31	0.44	0.88	0.00	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	10.06	0.56	0.56	0.00	0.00	0.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	12.37	0.44	0.44	1.32	0.00	0.44	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	11.96	0.39	2.31	1.16	0.39	0.00	0.39	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	5.57	0.51	2.03	1.01	0.00	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	13.46	0.48	0.48	0.48	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	10.73	0.40	1.19	1.19	0.80	1.59	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	9.72	1.22	0.00	3.04	0.00	0.00	0.00	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	6.92	1.38	0.69	0.00	0.00	0.69	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	10.64	0.76	0.38	2.66	0.76	0.38	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	9.30	1.55	1.03	1.03	0.00	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	4.84	0.00	0.00	1.81	0.00	1.21	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	10.14	1.27	0.95	1.27	0.63	0.63	0.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	10.66	0.53	0.53	0.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	8.62	0.57	1.15	1.15	0.00	1.15	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	6.69	0.51	0.51	0.51	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	9.20	0.00	0.71	0.00	0.00	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	9.08	1.13	0.00	2.84	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	7.49	2.08	0.83	0.42	0.00	0.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	7.83	2.35	1.57	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.02	0.84	0.00	0.42	0.00	1.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	7.90	0.00	0.46	0.93	0.00	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	6.69	1.34	0.00	0.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	10.69	0.00	0.00	0.00	0.00	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	9.29	0.00	0.81	0.00	0.00	0.40	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.01	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.00	0.00	0.00	2.67	0.00	0.89	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	10.26	0.57	0.57	0.57	0.57	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.14	0.00	0.77	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	7.11	1.09	1.64	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	7.57	0.45	1.34	0.89	0.00	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	12.74	1.04	0.00	1.30	0.00	0.78	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	6.63	0.66	1.33	0.66	0.00	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	6.24	0.00	0.00	2.08	4.16	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	54.93	0.00	2.05	2.73	0.00	2.51	0.68	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	40.56	0.92	1.65	2.02	0.18	2.02	0.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	32.90	0.66	1.31	1.31	0.00	0.92	0.66	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	9.56	1.06	1.06	1.06	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	25.99	0.63	1.74	2.06	0.00	1.43	0.79	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	24.32	3.34	1.25	1.67	0.56	1.11	0.14	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	12.56	12.36	9.07	2.69	1.10	1.00	1.59	0.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	9.27	8.40	2.03	2.61	0.87	0.87	0.29	0.87	0.00
Mammary Epithelial Cell, donor3	11422-118F9	4.99	0.50	0.50	1.00	0.00	0.00	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	45.42	406.76	3.39	6.10	28.47	0.68	0.68	12.20	0.00
Mast cell, donor1	11563-120D6	26.82	31.25	0.54	3.89	2.92	1.30	0.43	1.30	0.11
Mast cell, donor2	11565-120D8	34.18	84.10	0.30	2.97	7.73	0.59	1.19	0.30	0.89
Mast cell, donor3	11566-120D9	35.12	88.92	2.70	6.75	8.78	0.90	1.58	0.23	0.45
Mast cell, donor4	11567-120E1	40.07	80.31	2.66	4.43	6.56	0.89	1.24	0.71	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	49.24	63.21	0.89	3.77	4.32	2.33	0.33	0.89	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	39.11	170.44	6.42	9.34	17.51	1.17	1.17	7.00	0.58
Mast cell, expanded, donor5	11939-126A4	28.11	23.86	0.23	2.29	2.18	1.38	0.23	0.57	0.11
Mast cell, expanded, donor8	11941-126A6	64.10	169.21	8.03	17.57	13.89	0.67	1.34	4.18	0.67
Melanocyte - dark, donor1	11502-119F8	17.71	2.09	20.60	15.32	0.10	0.60	5.37	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	14.88	13.15	0.69	1.38	1.04	0.69	0.00	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	93.38	66.65	2.83	4.35	7.82	4.56	0.87	7.61	0.51
Melanocyte - light, donor1	11274-116H5	24.92	12.69	1.65	1.41	1.18	0.24	0.24	0.47	0.00
Melanocyte - light, donor2	11351-117H1	12.97	4.09	0.00	0.68	2.05	0.00	0.00	0.68	0.68
Melanocyte - light, donor3	11423-118G1	6.07	2.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	65.60	30.93	1.04	3.02	3.64	2.50	0.83	3.23	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	59.17	31.47	5.92	6.72	4.03	1.88	0.81	2.96	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	72.59	42.59	2.41	5.09	6.16	1.34	0.54	2.95	0.27
Meningeal Cells, donor1	11493-119E8	23.20	3.35	0.87	0.74	0.37	1.36	0.00	0.00	0.00
Meningeal Cells, donor2	11573-120E7	18.93	2.64	0.44	1.32	0.88	1.32	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	34.48	7.99	1.71	1.22	1.22	1.79	0.57	0.16	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	40.49	5.70	0.86	0.57	1.43	0.29	0.29	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	35.02	11.27	2.21	3.42	1.21	1.31	0.81	0.30	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	0.00	1.31	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	15.07	3.59	0.00	0.00	0.72	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	15.88	4.24	0.64	0.64	0.21	1.27	0.21	0.21	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	13.07	3.02	0.50	1.51	0.50	1.01	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	12.97	1.54	0.66	0.00	0.22	0.00	0.22	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	12.42	0.00	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.55	1.23	0.41	0.00	0.00	1.02	0.20	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	36.84	2.49	0.69	1.25	0.28	1.80	0.14	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.06	0.37	0.00	0.00	0.00	1.12	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	43.95	9.60	0.66	1.45	0.79	1.71	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.31	2.08	0.30	0.00	0.00	1.19	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	4.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.25	2.56	0.00	0.00	0.00	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	21.98	7.80	1.77	1.06	0.71	0.71	0.00	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	42.22	7.82	1.25	2.19	1.25	2.81	0.31	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	13.06	5.81	0.00	0.00	2.18	1.45	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	36.86	2.65	1.86	2.39	0.80	0.80	0.53	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	24.02	1.50	1.50	2.00	0.50	1.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	18.43	1.81	1.59	1.37	0.43	0.43	0.36	0.07	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	18.90	1.35	2.70	2.70	0.00	4.05	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	28.08	0.99	4.43	3.45	0.00	0.99	1.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	34.45	0.59	3.53	1.77	0.29	2.65	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	3.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	28.21	0.93	3.41	2.48	0.00	0.62	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	23.03	0.21	2.70	2.70	0.00	0.62	1.04	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	0.00	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	26.78	0.50	2.25	2.75	0.50	0.50	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	26.53	1.40	2.79	3.72	0.00	0.93	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	20.32	0.61	2.64	1.02	0.00	0.81	0.41	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	29.30	1.58	2.38	1.98	0.40	0.00	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	12.39	0.00	0.88	0.88	0.88	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	25.46	0.76	2.66	0.76	0.76	0.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	2.63	0.00	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	16.13	0.64	1.06	2.55	0.21	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	7.37	0.00	0.00	0.00	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.71	0.30	0.89	0.30	0.30	0.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	0.00	1.68	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	11.04	1.51	1.76	1.25	0.25	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	17.11	0.71	2.85	1.43	0.00	0.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	7.74	0.55	1.66	0.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	13.58	0.92	2.99	2.30	0.00	0.69	0.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	19.98	0.84	3.37	2.94	0.00	2.10	0.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	13.45	2.04	1.02	1.02	0.00	0.20	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	17.38	0.43	2.79	1.93	0.00	0.64	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	14.67	0.44	1.56	1.11	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.45	0.00	1.31	1.53	0.00	0.44	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.56	0.00	1.52	1.01	0.00	0.00	1.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	0.00	0.00	0.00	0.00	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.87	0.54	2.17	1.09	0.00	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	14.70	0.59	1.47	0.88	0.00	0.59	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	0.00	0.00	2.18	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	6.25	0.96	0.96	0.96	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	15.61	0.40	2.40	2.40	0.00	0.40	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	0.00	0.00	1.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.51	0.00	0.50	1.00	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	11.39	0.44	0.44	1.75	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	0.00	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	0.00	0.64	1.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	10.16	0.74	0.50	0.74	0.00	0.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	5.57	0.00	2.09	1.39	0.00	0.00	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	0.00	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	12.31	0.00	2.05	0.68	0.34	0.00	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5.25	0.44	1.75	1.75	0.00	0.44	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.33	0.00	2.13	2.13	0.00	0.00	1.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	8.98	0.00	1.12	1.68	0.00	0.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	8.73	0.00	2.91	1.66	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	9.95	0.00	1.21	1.21	0.00	0.00	0.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	10.43	0.00	3.76	3.34	0.00	0.42	2.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	0.92	2.77	2.77	0.00	0.92	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	7.97	1.14	2.28	5.12	0.00	0.00	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	11.75	0.00	1.93	1.66	0.00	0.14	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.11	0.52	1.30	2.07	0.00	0.52	0.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.30	0.43	3.86	2.57	0.00	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.35	0.00	0.64	1.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	8.81	0.00	1.07	2.67	0.00	0.27	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	24.84	1.50	1.80	1.80	0.60	1.20	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.89	0.85	1.27	1.13	0.00	0.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	11.47	0.32	1.59	2.23	0.00	0.64	1.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	13.49	0.00	3.10	4.42	0.00	0.00	1.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	8.72	0.00	0.76	1.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	13.35	0.57	3.13	3.41	0.28	0.85	1.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	15.49	0.25	3.20	4.18	0.00	0.49	0.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.21	0.00	0.00	3.26	0.65	0.00	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	15.58	1.18	2.06	1.47	0.29	0.88	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	18.16	0.58	1.73	1.73	0.29	1.15	2.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	24.32	2.89	3.71	4.53	0.00	0.41	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	11.61	0.00	0.60	1.79	0.00	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	14.26	1.78	0.00	0.00	0.00	1.78	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	23.00	0.00	2.30	1.64	0.00	0.99	0.99	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	36.82	2.10	1.05	2.10	0.00	3.16	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	32.42	0.20	4.35	2.37	0.00	0.99	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	23.28	0.93	5.59	2.79	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	24.78	0.00	3.38	1.50	0.00	1.88	1.50	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	21.31	0.00	0.53	1.07	0.00	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	28.28	0.00	2.71	1.92	0.00	1.58	0.68	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	14.00	0.74	1.47	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	20.15	0.00	1.47	1.10	0.00	0.73	0.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	34.22	0.00	1.56	0.00	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	25.12	0.00	0.53	3.21	0.00	0.53	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	19.19	0.00	1.01	1.01	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	20.66	0.42	0.84	2.11	0.00	1.69	0.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	0.64	1.27	1.27	0.00	1.91	1.91	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.10	1.62	0.81	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	0.00	1.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	0.00	0.00	0.00	0.00	0.00	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	19.57	6.52	16.31	3.26	6.52	3.26	9.79	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00	4.75	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	25.64	4.96	2.37	1.72	0.86	1.72	0.65	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	20.38	6.27	1.57	2.09	1.57	1.05	0.52	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.68	2.00	1.33	2.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	11.27	0.42	0.42	1.67	0.00	0.00	0.83	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	42.97	3.80	3.80	4.94	0.38	1.71	0.95	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	23.94	6.38	1.60	1.60	0.00	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.84	0.68	1.36	1.36	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	88.21	11.03	14.70	12.86	0.00	1.84	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.44	1.67	0.42	0.84	0.84	0.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	17.43	0.46	2.79	2.32	0.23	0.46	0.93	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	13.78	1.35	1.62	1.35	0.54	0.54	0.81	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	18.50	6.10	3.99	1.68	1.05	1.47	0.84	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	289.50	0.00	22.27	22.27	0.00	0.00	22.27	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	11.91	1.99	1.99	0.00	0.99	0.50	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	29.50	4.33	1.89	4.60	0.81	0.54	0.81	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.28	1.36	1.59	0.91	0.23	0.91	0.23	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	12.41	1.47	1.14	0.82	0.00	0.33	0.49	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	20.23	5.83	3.83	3.46	0.00	1.28	1.28	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.32	1.06	3.71	1.06	0.00	0.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.60	0.60	3.00	1.20	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	59.73	3.94	5.58	5.91	0.98	0.98	0.66	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.41	0.49	0.98	0.65	0.00	0.65	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	22.05	2.29	2.82	2.65	0.18	0.71	0.71	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.85	0.00	2.11	2.11	0.00	0.00	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	15.17	1.84	2.30	1.84	0.00	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	15.42	2.25	3.53	0.32	0.00	0.00	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	48.63	4.48	5.52	5.52	0.34	1.38	2.07	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	93.55	0.00	0.00	12.64	0.00	7.59	7.59	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	21.16	2.90	2.23	2.01	0.22	1.34	0.67	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.13	1.69	2.12	0.85	0.00	0.42	1.27	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	22.79	2.37	3.32	2.14	0.71	0.47	0.95	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	14.17	0.86	0.86	1.29	0.43	0.86	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	306.94	18.06	18.06	27.08	0.00	9.03	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	15.99	1.67	1.33	2.67	0.00	1.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	6.31	2.25	1.35	1.80	0.45	0.00	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.11	1.59	0.40	0.40	0.40	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	9.29	4.64	0.00	0.93	0.00	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	29.13	3.03	1.14	3.78	0.00	0.76	1.51	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	12.38	3.26	1.30	0.65	0.00	0.65	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	4.79	1.74	0.44	1.74	0.00	0.44	1.31	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.90	2.71	3.17	0.90	0.45	0.90	0.90	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.99	0.88	0.00	0.88	0.00	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	12.63	1.99	0.00	0.66	0.66	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	23.31	0.99	0.99	1.49	0.50	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.80	0.00	0.77	0.38	0.00	0.38	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	54.14	4.84	2.42	2.12	1.21	2.12	1.81	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	17.68	1.99	1.11	2.21	0.66	0.44	0.22	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.84	2.03	1.36	1.36	0.68	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	143.07	0.00	20.44	25.55	10.22	10.22	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.12	1.83	1.22	1.22	0.00	1.83	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.33	1.26	0.00	0.31	0.31	0.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	14.53	1.51	0.00	1.21	0.30	0.61	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	16.61	2.37	0.00	0.79	0.79	0.79	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	53.28	7.94	5.67	7.94	0.00	1.13	4.53	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	171.97	10.12	35.41	10.12	0.00	15.17	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	32.05	1.61	2.73	1.99	0.00	1.49	0.62	0.12	0.00
Myoblast, donor2	11322-117D8	30.49	1.15	4.41	2.69	0.38	1.15	0.38	0.00	0.00
Myoblast, donor3	11398-118D3	32.29	1.35	6.89	4.04	0.17	2.19	1.68	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	50.05	0.00	0.58	0.88	0.00	1.46	0.15	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	74.42	6.46	1.23	2.77	0.62	2.15	0.31	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	38.90	5.13	0.00	0.60	0.30	1.21	0.60	0.60	0.00
Natural Killer Cells, donor3	11387-118C1	55.77	6.63	0.74	1.29	0.37	0.92	0.55	0.00	0.00
Neural stem cells, donor1	11275-116H6	69.32	130.30	5.81	5.44	14.52	7.98	2.54	2.90	0.36
Neural stem cells, donor2	11352-117H2	61.62	92.43	7.70	0.00	7.70	7.70	0.00	3.85	0.00
Neurons, donor1	11494-119E9	34.14	36.41	4.55	0.00	3.41	4.55	0.00	1.14	1.14
Neurons, donor2	11574-120E8	40.07	43.81	0.22	1.10	5.94	3.74	0.22	0.66	1.54
Neurons, donor3	11655-122E8	27.95	55.09	2.47	2.47	5.76	2.47	0.82	1.64	0.82
Neutrophils, donor1	11233-116C9	48.26	17.63	1.86	0.00	1.86	0.00	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	26.09	8.70	0.00	0.00	5.80	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	57.42	31.76	1.22	2.44	9.77	0.61	0.00	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	35.98	3.80	2.61	1.54	0.12	3.68	0.59	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	12.05	1.63	1.63	0.65	0.00	0.33	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	23.46	4.01	1.20	1.60	0.40	1.20	0.40	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	11.29	2.62	0.96	0.96	0.28	0.55	0.28	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	19.97	4.34	2.03	1.74	1.01	0.87	1.01	0.14	0.00
Olfactory epithelial cells, donor3	11935-125I9	17.82	2.61	1.93	0.79	0.34	0.57	0.23	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	18.51	0.88	2.73	0.88	0.39	0.49	0.29	0.10	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	49.35	3.61	1.20	0.60	0.00	1.81	1.20	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	20.42	2.55	0.43	1.49	0.64	1.49	0.21	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	20.58	3.43	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.03	2.48	0.00	0.62	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	6.84	4.69	0.78	0.20	0.98	1.17	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	34.41	4.92	1.40	3.51	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	12.80	2.49	0.18	0.71	0.18	0.89	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	44.06	12.38	3.96	2.02	1.68	1.85	0.51	0.59	0.17
Pericytes, donor1	11491-119E6	6.23	0.89	0.67	0.22	0.00	0.56	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	5.43	0.91	0.23	0.23	0.00	0.45	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	6.31	2.64	0.00	0.00	0.41	0.20	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	38.77	6.33	0.34	0.23	1.02	2.71	0.23	0.00	0.11
Perineurial Cells, donor2	11579-120F4	29.44	14.08	1.93	3.22	1.38	1.38	0.92	0.18	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	48.45	7.97	0.64	4.46	1.59	2.23	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	35.75	10.53	1.71	3.67	0.73	0.73	0.24	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	23.29	4.01	0.13	0.65	0.78	0.52	0.00	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	7.65	0.96	0.48	1.20	0.24	0.24	0.48	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	8.87	3.33	2.22	0.00	2.22	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	10.01	1.96	0.59	0.00	0.20	0.00	0.20	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	13.61	0.63	0.95	1.58	0.00	0.95	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	23.45	2.81	4.13	3.19	0.00	0.75	0.75	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	28.59	1.44	3.39	3.13	0.00	1.31	1.17	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	19.14	1.13	1.35	0.90	0.00	0.45	0.90	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	35.38	9.59	5.33	3.09	1.28	1.17	1.28	0.21	0.32
Preadipocyte - omental, donor2	11329-117E6	39.72	3.06	4.36	2.62	0.44	0.87	1.31	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	26.93	3.44	2.44	2.58	0.86	1.00	0.57	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	6.89	0.98	0.00	0.00	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	10.44	2.76	1.23	0.92	0.31	0.31	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	21.25	6.20	1.06	1.06	0.35	0.89	0.35	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	14.30	2.55	3.58	2.38	0.51	1.02	0.34	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	35.21	12.48	6.80	3.45	1.30	1.02	1.12	0.09	0.19
Preadipocyte - visceral, donor2	11357-117H7	23.47	11.96	4.60	2.30	1.38	0.46	0.92	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	16.51	3.13	3.45	0.94	0.31	0.31	0.73	0.00	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	28.51	9.50	0.75	2.11	0.45	0.45	0.00	0.45	0.00
Prostate Epithelial Cells, donor2	11331-117E8	18.55	0.00	0.27	0.27	0.00	1.08	0.68	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	25.47	19.72	1.22	0.61	3.98	1.22	0.37	0.61	0.18
Prostate Stromal Cells, donor1	11254-116F3	28.93	13.78	1.48	2.96	2.05	1.59	0.34	0.57	0.00
Prostate Stromal Cells, donor2	11332-117E9	30.48	8.43	1.61	1.97	1.43	2.33	0.36	0.18	0.00
Prostate Stromal Cells, donor3	11405-118E1	17.62	3.86	0.94	1.04	0.21	1.04	0.52	0.31	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	10.22	2.19	0.00	0.36	0.36	1.46	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	43.87	7.07	0.28	0.28	1.32	3.95	0.21	0.07	0.00
Renal Epithelial Cells, donor1	11517-119H5	7.61	0.51	0.00	0.00	0.00	1.52	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	7.11	0.71	0.00	0.00	0.00	0.71	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	53.14	10.16	0.42	0.74	1.27	5.61	0.32	0.00	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.13	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	9.30	1.21	1.21	2.43	0.13	0.27	0.27	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	20.20	3.77	4.00	3.33	1.11	1.33	1.55	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	0.00	0.00	0.67	0.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	8.58	2.20	0.00	0.88	0.22	1.54	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	11.29	0.63	1.25	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.16	0.83	0.00	0.00	0.00	0.00	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	25.23	2.42	0.00	0.00	0.27	0.54	0.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.43	1.69	0.00	0.42	0.00	0.00	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	10.41	1.74	0.00	0.19	0.19	0.58	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	63.26	15.30	0.78	1.81	2.59	2.85	0.26	0.52	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	29.28	3.98	0.85	1.14	0.28	1.42	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	4.12	0.00	0.00	1.03	2.06	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	40.65	52.69	2.01	1.51	5.77	3.01	0.75	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	46.10	8.02	9.09	6.82	0.40	2.67	2.94	0.53	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	25.91	20.55	0.89	0.89	3.57	2.68	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	66.04	39.63	0.55	4.95	6.05	3.30	0.55	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	51.62	24.36	1.74	3.48	0.58	3.48	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	53.05	17.03	2.34	5.07	2.21	2.60	1.17	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	35.55	11.52	0.70	2.38	0.89	1.39	0.30	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	53.65	18.63	1.34	2.79	1.67	2.45	0.33	0.22	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	63.63	17.12	2.36	4.96	2.60	2.48	0.74	0.12	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	43.01	12.82	1.28	1.98	1.75	1.40	0.23	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	52.70	16.64	1.85	4.39	1.62	1.39	0.69	0.23	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	38.61	11.23	1.64	2.46	1.51	2.33	0.41	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	44.63	14.22	1.66	2.87	0.91	1.82	0.61	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	47.49	15.23	1.25	3.40	2.33	1.97	0.54	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	38.45	10.04	1.58	2.58	1.29	1.15	1.00	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	39.17	12.66	0.64	1.82	1.61	1.07	0.32	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	44.03	12.39	1.55	3.76	1.11	0.66	0.66	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	34.41	9.18	0.57	2.68	0.96	0.76	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	38.48	12.76	1.02	2.05	0.75	1.21	0.56	0.19	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	55.81	22.74	2.63	1.69	2.25	2.44	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	37.69	8.36	0.93	2.12	1.19	1.19	0.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	38.16	10.71	1.46	2.34	0.88	0.78	0.97	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	44.30	11.27	1.72	2.86	0.95	2.10	0.38	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	34.39	9.40	1.17	2.03	1.92	1.28	0.75	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	35.32	17.94	1.12	2.80	0.28	1.12	1.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	37.94	11.11	1.54	2.39	1.20	1.71	0.51	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	32.09	9.30	1.28	2.19	1.28	0.91	0.55	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	32.62	9.93	0.74	3.07	1.47	1.59	0.25	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	38.95	10.07	0.67	1.48	1.07	0.94	0.00	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	34.91	11.56	0.47	2.36	1.89	2.12	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	38.10	12.90	1.79	2.38	0.99	0.99	0.20	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	44.20	11.69	1.17	2.57	1.64	1.40	0.47	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	35.46	9.95	0.83	1.66	0.83	1.87	0.21	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	31.63	17.25	2.21	2.43	0.44	1.11	1.55	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	36.76	10.03	1.46	2.51	0.63	1.88	0.63	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	44.41	7.00	0.94	2.83	1.08	1.75	0.67	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	36.61	13.11	1.36	1.53	0.85	1.02	1.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	40.29	8.68	1.35	2.51	0.77	2.70	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	41.78	11.18	1.38	2.75	2.24	1.38	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	40.19	10.70	1.51	3.70	0.96	0.82	0.69	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	49.74	15.27	1.81	4.43	0.99	2.63	0.66	0.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	34.43	12.95	1.53	3.24	1.19	0.85	0.68	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	42.17	14.06	1.92	3.40	0.89	1.18	1.04	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	31.99	11.99	1.33	2.93	1.33	1.33	0.80	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	37.06	13.14	0.97	1.52	2.49	1.38	0.28	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	37.62	4.05	1.67	1.90	0.48	2.86	0.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	50.18	9.47	1.01	3.43	1.01	2.82	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	32.58	10.08	1.70	1.88	1.04	1.13	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	43.67	37.73	0.70	2.45	4.19	1.05	1.05	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	34.15	21.15	2.72	2.42	3.63	1.51	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	29.13	7.83	1.10	2.33	0.49	1.59	0.00	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	76.12	80.34	2.33	4.51	8.73	4.37	0.58	0.73	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	40.16	41.37	0.00	3.04	4.26	1.83	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	28.63	6.93	1.21	1.81	0.60	1.81	0.00	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	45.24	39.13	0.23	2.26	3.62	2.04	0.23	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	51.82	25.16	0.90	1.50	2.70	4.49	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	49.24	29.40	0.94	2.95	3.07	1.65	0.59	0.35	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	37.57	41.62	1.28	2.35	5.12	1.92	0.21	0.43	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	41.47	43.87	1.20	1.80	6.01	1.80	1.20	0.00	0.60
Schwann Cells, donor1	11498-119F4	4.89	0.38	0.00	0.00	0.19	0.56	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	27.22	6.80	0.00	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	18.62	5.48	0.66	0.66	0.00	0.66	0.00	0.00	0.00
Sebocyte, donor1	11220-116B5	20.27	1.64	0.55	0.55	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	12.41	0.92	0.46	0.46	0.00	0.00	1.38	0.00	0.00
Sebocyte, donor3	11378-118B1	10.10	0.62	0.00	0.21	0.00	0.62	0.00	0.21	0.00
Sertoli Cells, donor1	11255-116F4	28.16	13.25	1.66	3.31	0.00	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	11.30	2.82	5.65	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	32.99	16.72	1.67	1.32	1.94	1.32	0.18	0.18	0.18
Skeletal Muscle Cells, donor2	11358-117H8	3.61	3.61	0.72	0.72	0.00	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	15.05	0.00	0.00	0.84	0.00	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	27.02	4.40	1.26	1.10	0.47	1.41	0.31	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	25.57	5.80	0.30	1.04	0.89	0.45	0.00	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	30.93	4.92	0.62	0.31	0.46	0.92	0.31	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	52.42	10.21	3.78	2.65	1.01	3.78	0.38	0.13	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	27.82	4.42	1.00	1.00	0.57	2.14	0.14	0.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	29.66	4.66	1.09	0.20	0.50	1.09	0.30	0.20	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	25.53	6.91	2.02	1.94	0.67	1.35	0.51	0.17	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.96	2.90	0.00	0.00	0.00	2.17	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5.78	2.61	1.51	0.55	0.28	0.41	0.14	0.14	0.00
Skin - palm, donor1	10286-104F7	2.69	8.06	5.37	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	10.38	0.14	0.58	0.14	0.00	1.01	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	62.16	0.82	5.73	0.00	0.00	7.36	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.83	0.39	0.65	0.39	0.00	0.52	0.00	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	23.49	16.40	1.11	1.11	1.95	1.67	0.56	0.14	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	12.38	3.66	0.56	1.83	0.28	0.00	0.42	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	76.97	4.23	3.81	2.11	0.63	3.38	1.27	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	15.81	9.82	0.60	0.30	1.27	0.60	0.30	0.15	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	7.41	1.54	0.31	0.00	0.62	0.62	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	45.58	13.34	1.11	1.56	2.22	3.11	0.44	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	17.63	1.76	1.18	0.59	0.00	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	8.84	3.09	1.10	1.10	0.00	0.22	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	9.06	3.15	0.79	0.39	0.00	0.00	0.79	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	16.22	2.32	0.77	0.77	0.77	1.55	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	14.01	6.00	1.00	0.00	2.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	14.64	1.20	0.40	0.53	0.27	0.27	0.13	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	23.72	7.31	3.32	1.33	0.22	1.11	1.11	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	22.15	6.27	2.18	1.28	0.77	1.28	0.51	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	33.21	4.88	1.95	0.98	0.00	1.95	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	40.16	5.61	1.48	2.66	1.18	2.07	0.89	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	21.78	3.42	0.28	0.71	1.57	1.00	0.14	0.00	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.88	0.98	0.00	0.16	0.00	0.16	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	23.14	18.57	0.61	1.22	1.52	0.91	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	14.40	5.56	0.76	0.51	0.51	0.00	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.29	0.48	0.48	0.00	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	33.48	3.69	0.74	1.92	0.15	1.33	0.29	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	21.31	4.52	1.94	0.43	0.43	1.08	0.00	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	27.18	4.30	0.52	0.94	0.84	1.05	0.10	0.42	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	11.91	2.17	0.77	0.62	0.15	0.31	0.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	12.93	2.16	0.00	2.16	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	13.15	0.90	0.90	1.20	0.00	0.30	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.10	1.02	0.00	0.00	0.00	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	26.39	4.95	0.31	0.71	0.79	1.49	0.08	0.00	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	39.85	6.34	0.91	1.01	0.50	1.51	0.00	0.10	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	17.75	3.87	4.32	2.96	0.46	0.46	0.00	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.25	0.60	1.21	0.00	0.00	1.21	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	33.12	4.77	0.00	0.79	0.26	1.59	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	36.22	10.39	1.60	2.80	1.73	1.33	0.67	0.40	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	23.54	10.39	1.13	1.25	1.75	0.75	0.25	0.13	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	26.89	8.62	1.78	1.78	1.27	1.01	0.51	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	23.22	6.03	3.17	1.96	0.90	1.21	0.90	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	7.50	4.50	0.00	0.75	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	7.75	0.00	0.00	1.29	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	14.88	3.26	1.86	0.93	0.47	0.47	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	14.14	2.02	0.50	1.01	0.00	0.50	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	17.55	2.82	0.63	1.25	0.31	0.63	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.83	0.59	0.00	0.29	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	28.91	5.66	1.42	1.33	0.67	2.00	0.25	0.08	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	18.69	1.87	0.00	0.47	0.47	1.40	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	12.09	2.30	0.72	0.43	0.43	0.14	0.00	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	8.92	1.53	1.53	0.76	0.25	0.25	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	7.15	2.82	0.19	0.19	0.00	0.38	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	35.91	9.78	0.28	0.98	1.12	3.07	0.56	0.00	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	24.89	7.71	0.17	0.25	1.76	1.84	0.00	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	0.00	0.00	0.00	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	12.72	0.73	0.00	0.24	0.49	0.24	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	29.39	4.20	1.55	3.54	1.99	1.10	0.88	0.44	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	28.67	33.65	2.05	1.76	3.22	2.05	0.00	2.05	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	21.77	3.50	0.97	1.17	0.78	1.17	0.00	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	17.98	4.76	1.85	2.91	1.59	0.26	0.26	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	44.63	5.21	1.86	2.23	0.37	2.98	0.74	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	38.45	5.03	0.72	0.36	0.00	2.87	0.72	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	24.70	4.54	2.84	2.27	0.28	1.14	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	19.30	4.33	0.39	1.58	0.39	0.79	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	22.60	3.05	2.54	1.02	0.00	1.02	0.25	0.76	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	30.75	2.40	0.00	1.20	1.60	1.60	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	13.79	5.43	1.25	0.84	1.25	0.84	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	13.29	7.79	1.83	1.38	0.92	0.46	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	13.80	3.37	0.50	0.84	0.50	0.34	0.00	0.17	0.17
Synoviocyte, donor2	11368-117I9	12.24	2.51	4.86	1.01	0.00	0.84	0.67	0.00	0.00
Synoviocyte, donor3	11440-118H9	14.30	2.01	3.35	1.79	0.22	0.67	0.89	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	5.36	2.86	0.00	0.71	1.07	1.07	0.36	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	3.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.57	4.17	0.00	0.00	0.23	0.46	0.00	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	12.04	6.31	1.15	0.22	0.93	0.65	0.29	0.43	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	4.64	1.55	0.00	0.00	0.39	0.00	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	6.30	1.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	46.38	9.35	8.73	5.66	0.74	1.60	2.83	0.37	0.00
Urethra, donor2	10319-105A4	34.17	14.39	7.19	7.19	5.40	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	5.31	0.80	0.00	0.00	0.00	0.27	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	5.21	0.00	0.00	0.00	0.00	0.40	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	4.35	0.69	0.00	0.23	0.69	0.23	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	33.66	2.90	1.11	0.22	2.01	1.56	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	88.98	132.58	0.00	1.78	51.61	0.89	0.00	8.90	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	87.21	137.24	2.86	0.00	45.75	1.43	1.43	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	47.92	68.45	0.00	0.68	17.11	0.68	0.00	2.05	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	55.09	94.35	0.00	0.69	26.17	1.38	0.00	1.38	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	41.25	83.09	0.58	0.58	18.59	1.74	0.00	1.74	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	61.43	97.88	0.00	3.12	45.81	4.16	0.00	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	77.09	122.98	0.92	0.92	46.81	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	29.21	62.08	0.00	0.00	22.82	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	14.56	2.47	2.10	1.73	0.00	0.99	0.62	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	14.08	0.00	2.64	0.00	0.00	0.88	2.64	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	31.84	9.78	0.84	0.28	0.84	1.68	0.00	0.84	0.00
achilles tendon, donor2	10292-104G4	16.53	6.20	10.33	4.13	0.00	4.13	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	58.13	6.37	0.25	2.29	0.25	2.55	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	39.93	0.00	0.00	0.00	0.00	3.02	0.23	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	52.94	22.67	0.24	0.12	2.02	5.34	0.00	0.24	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	56.87	18.50	0.54	0.54	1.63	3.27	0.00	0.27	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	4.78	5.34	0.00	0.00	0.56	0.56	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	26.01	0.00	0.21	1.90	0.00	1.69	0.21	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	20.96	20.14	0.82	0.27	1.09	3.81	0.00	0.54	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	17.63	0.00	0.00	0.88	0.00	0.44	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	22.46	0.00	0.00	0.00	0.00	2.04	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	22.91	2.33	0.78	2.33	0.00	2.33	0.00	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	17.85	0.92	0.18	0.00	0.00	2.02	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	0.00	0.00	0.00	0.00	7.80	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	29.51	0.00	1.39	1.39	0.00	2.09	0.23	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	47.90	0.00	0.26	0.78	0.26	5.44	0.26	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	31.56	1.17	0.00	0.00	0.00	6.43	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	26.03	0.46	0.93	0.93	0.46	2.79	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	9.05	0.00	0.00	0.41	0.00	2.06	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	7.67	0.00	0.31	0.00	0.00	0.92	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	26.46	0.00	0.43	1.28	0.00	2.99	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	28.21	0.00	0.00	0.30	0.00	2.12	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	32.50	0.48	0.00	1.68	0.00	1.93	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	17.60	4.45	0.00	0.45	0.67	1.56	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	27.68	11.01	0.00	0.67	1.33	0.67	0.00	1.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	20.44	13.01	0.00	1.86	1.86	3.72	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	24.48	9.42	0.00	1.13	0.75	2.26	0.00	1.13	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	22.68	8.29	0.00	0.00	0.87	1.74	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	7.50	0.00	0.00	1.87	0.00	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	46.63	45.45	1.41	0.71	6.59	0.47	0.71	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	32.73	2.17	6.52	4.03	0.00	1.71	1.55	0.00	0.00
adipose, donor1	10184-103D4	90.89	38.12	1.17	7.62	12.90	9.38	2.93	0.00	1.17
adipose, donor2	10185-103D5	17.84	30.01	8.52	4.06	5.27	2.84	3.24	0.41	0.41
adipose, donor3	10186-103D6	22.87	26.41	6.26	5.72	4.63	2.72	4.36	0.27	0.54
adipose, donor4	10187-103D7	30.34	9.53	1.73	0.87	11.27	0.87	0.87	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	29.04	0.00	1.42	2.37	0.00	1.10	1.26	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	25.46	14.55	0.00	10.91	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	24.28	0.00	0.13	0.00	0.00	2.80	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	21.08	17.51	3.22	1.43	1.79	0.36	0.00	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	33.15	8.58	3.01	0.46	1.85	1.85	0.46	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	38.54	8.45	3.72	2.03	1.35	2.70	0.68	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	32.11	8.84	5.30	0.88	1.18	3.83	0.59	0.29	0.00
amygdala - adult, donor10196	10167-103B5	88.93	78.26	3.56	4.74	17.79	4.74	0.00	1.19	2.37
amygdala, adult, donor10252	10151-102I7	67.52	61.64	3.45	4.26	7.71	4.66	1.42	1.01	2.43
amygdala, newborn, donor10223	10360-105E9	38.41	51.97	1.61	0.65	12.27	1.61	0.00	1.94	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	45.20	3.82	0.64	1.53	1.40	2.04	0.13	0.13	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	24.05	5.74	0.22	0.66	0.44	0.44	0.00	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	49.77	0.00	0.33	0.67	0.00	3.34	0.67	0.00	0.00
aorta, adult, pool1	10052-101G7	19.02	6.47	4.51	1.77	1.37	0.98	1.18	0.20	0.20
appendix, adult	10189-103D9	45.80	6.60	5.82	3.88	1.55	1.55	0.39	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	51.25	13.07	6.19	7.22	2.75	2.41	3.44	0.34	0.00
artery, adult	10190-103E1	24.46	6.79	1.36	0.00	2.72	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	38.97	14.78	1.59	3.04	0.72	1.74	0.87	0.43	0.00
b cell line:RPMI1788	10427-106D4	34.05	5.20	0.45	1.19	0.30	1.64	0.30	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	28.85	5.27	1.39	1.11	0.55	1.66	0.28	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	29.17	7.94	0.30	1.29	1.49	1.59	0.10	0.10	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	45.36	91.39	1.34	2.34	3.68	0.17	0.50	2.85	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	16.22	0.56	0.00	0.00	0.00	2.80	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	24.55	23.90	9.02	2.93	2.06	0.76	1.52	1.09	0.00
blood, adult, pool1	10053-101G8	17.72	59.79	0.00	0.00	17.72	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	27.40	0.86	7.71	1.71	0.00	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	26.32	4.05	4.05	1.35	0.67	1.35	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	45.10	55.35	1.03	4.10	10.25	5.13	1.03	0.00	2.05
brain, adult, pool1	10012-101C3	70.38	75.17	3.12	3.67	12.81	6.90	2.45	2.12	2.12
brain, fetal, pool1	10085-102B4	32.06	82.81	0.00	2.67	8.01	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	15.86	2.31	2.97	1.65	0.33	0.66	0.33	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	66.78	4.49	1.87	2.75	0.25	2.12	0.75	0.25	0.00
breast, adult, donor1	10080-102A8	15.15	0.00	2.53	2.53	0.00	0.00	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	22.49	14.86	1.14	1.14	2.16	0.89	0.64	0.38	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	47.00	20.10	0.93	1.24	1.55	4.02	0.31	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	33.15	22.56	4.83	2.99	2.53	1.84	1.15	1.38	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	35.83	12.10	7.26	1.45	0.24	0.73	0.97	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	27.27	6.58	0.00	0.00	1.41	2.35	0.47	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	16.74	13.45	0.55	0.66	0.66	0.77	0.11	0.22	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	48.17	30.74	0.63	0.63	3.49	2.22	0.00	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	45.52	23.16	3.19	2.13	2.40	3.73	0.80	0.53	0.00
caudate nucleus - adult, donor10196	10177-103C6	65.63	102.47	5.76	4.61	12.66	5.76	3.45	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	62.25	57.39	2.84	3.85	6.86	3.85	1.84	1.67	2.18
caudate nucleus, adult, donor10258	10379-105H1	55.02	71.83	3.82	0.76	14.52	4.58	0.76	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	69.95	111.70	2.20	4.76	12.82	4.39	0.37	2.93	1.46
cerebellum - adult, donor10196	10173-103C2	101.96	192.28	0.00	14.57	23.31	14.57	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	92.24	118.71	2.35	8.75	22.42	4.70	4.06	2.35	4.48
cerebellum, adult, pool1	10083-102B2	44.15	78.99	1.38	3.10	10.69	3.45	1.72	1.38	1.38
cerebellum, newborn, donor10223	10357-105E6	60.61	110.43	4.98	3.32	16.61	4.98	1.66	3.32	2.49
cerebral meninges, adult	10188-103D8	49.67	66.82	6.56	4.54	10.84	5.55	2.27	1.01	0.76
cerebrospinal fluid, donor2	10294-104G6	8.77	16.08	0.73	3.65	2.92	0.73	1.46	2.19	0.73
cervical cancer cell line:D98-AH2	10552-107I3	33.36	25.02	2.44	4.31	2.16	0.86	2.01	0.29	0.00
cervical cancer cell line:ME-180	10553-107I4	32.48	44.25	3.65	4.47	3.48	0.83	2.15	2.98	0.66
cervix, adult, pool1	10013-101C4	31.18	14.49	9.34	3.78	1.15	1.99	1.78	0.52	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	20.62	14.21	1.53	3.90	1.53	0.56	1.11	0.28	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	3.92	0.00	2.61	0.00	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	31.81	3.60	0.50	2.24	0.25	3.11	0.62	0.25	0.00
choriocarcinoma cell line:SCH	10785-110H2	35.12	2.09	2.96	2.71	0.12	0.62	1.85	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	18.97	1.66	0.95	1.66	0.24	0.24	0.24	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	23.93	3.13	4.56	1.99	0.28	1.99	1.14	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	29.53	3.38	2.98	2.68	0.70	0.50	1.79	0.10	0.10
chorionic membrane cells, donor3	12240-129G8	25.83	1.65	6.59	1.10	0.00	2.20	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	40.39	13.13	0.00	0.00	5.05	2.02	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	10.37	4.99	0.00	0.00	0.00	1.34	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	20.49	0.21	0.21	0.63	0.00	0.84	0.42	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	32.87	34.41	0.77	1.28	6.93	2.57	0.26	1.80	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	38.94	39.18	0.48	1.69	9.92	2.18	0.73	1.21	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	36.85	38.89	0.61	2.65	7.33	1.83	0.20	1.22	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	61.54	53.00	0.88	2.94	12.07	2.06	0.00	1.47	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	37.01	2.61	0.00	0.26	0.52	1.56	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	24.23	2.51	0.23	0.91	0.23	2.06	0.00	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	62.64	4.68	0.17	1.21	1.04	5.03	0.52	0.52	0.00
colon carcinoma cell line:CACO-2	10513-107D9	33.86	10.98	0.55	2.38	1.28	2.38	0.00	0.55	0.37
colon carcinoma cell line:COLO-320	10420-106C6	95.02	29.27	0.00	1.52	3.80	6.84	0.00	0.00	0.76
colon, adult, donor1	10082-102B1	30.94	26.18	5.95	1.19	2.38	2.38	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	36.78	24.21	5.05	2.59	2.12	0.82	1.18	0.12	0.12
colon, fetal, donor1	10070-101I7	24.72	35.84	10.51	1.24	1.85	0.00	1.85	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	18.33	4.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	79.89	51.84	2.97	5.95	2.55	5.95	0.42	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	33.96	13.58	0.60	2.57	0.75	1.51	0.15	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	42.16	13.54	0.28	2.12	0.28	2.54	0.28	0.14	0.00
corpus callosum, adult, pool1	10042-101F6	137.10	87.90	3.54	4.75	8.96	15.26	2.76	2.43	1.66
cruciate ligament, donor2	10295-104G7	22.69	3.24	6.48	3.24	0.81	0.00	0.00	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	17.66	18.46	4.01	3.21	2.41	1.61	0.00	0.80	0.00
diencephalon, adult	10193-103E4	49.20	68.40	1.44	3.60	6.48	6.48	1.68	0.96	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	30.77	1.15	0.00	0.92	0.23	1.38	0.46	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	40.52	32.57	0.51	1.54	3.59	1.28	0.26	1.80	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	26.00	34.42	4.09	2.17	2.89	0.96	0.72	1.44	0.00
ductus deferens, adult	10196-103E7	40.86	20.43	19.44	6.98	4.98	1.50	4.49	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	40.33	24.48	5.76	4.32	1.44	2.88	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	41.93	25.01	2.94	0.74	6.62	3.68	0.74	1.47	0.00
dura mater, adult, donor1	10041-101F5	13.38	7.35	11.48	4.71	1.16	0.25	2.64	0.08	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	16.43	28.65	0.67	4.44	1.78	1.33	0.67	3.55	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	30.09	11.61	0.86	1.15	0.86	1.86	0.29	0.43	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	12.95	6.78	1.23	0.62	1.23	0.00	0.62	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	20.58	7.57	1.51	0.61	0.30	2.12	0.61	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	13.58	13.58	1.23	1.85	1.54	0.62	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	22.33	1.31	0.00	1.31	0.00	1.31	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	21.45	16.76	2.68	2.68	0.67	0.34	0.34	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	40.23	29.00	2.17	3.08	1.63	1.09	1.09	0.18	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	35.38	3.06	1.29	2.09	0.64	2.09	0.32	0.32	0.32
epidermoid carcinoma cell line:A431	10426-106D3	40.80	5.89	0.33	0.56	0.56	3.11	0.22	0.44	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	29.81	4.73	0.44	0.99	0.44	1.87	0.00	1.10	0.00
epididymis, adult	10197-103E8	39.98	11.09	9.21	3.56	1.05	2.30	1.47	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	35.30	0.00	3.19	2.13	0.00	1.42	1.06	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	5.51	0.00	1.97	1.57	0.00	0.79	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	14.15	12.19	4.59	3.01	1.31	0.00	2.62	0.79	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	16.93	11.42	4.33	5.41	0.79	0.30	2.07	0.89	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	15.01	9.30	3.25	3.25	1.34	0.34	1.90	0.78	0.22
esophagus, adult, pool1	10015-101C6	34.30	27.50	9.87	3.19	2.23	1.91	2.34	2.44	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	71.51	139.26	19.41	9.77	2.88	2.38	2.50	1.63	0.25
eye - muscle inferior rectus, donor1	10272-104E2	14.49	4.83	7.24	9.66	2.41	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	4.21	4.21	0.00	0.00	4.21	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	13.39	7.44	2.98	1.49	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	19.49	5.73	8.03	2.29	0.00	0.00	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	11.66	11.66	4.37	2.91	2.91	0.00	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	41.19	45.76	5.85	1.78	8.14	4.32	1.78	6.86	3.56
fibrosarcoma cell line:HT-1080	10758-110E2	20.00	10.64	0.38	0.64	1.41	0.64	0.51	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	25.64	6.65	2.85	2.37	0.95	0.95	0.95	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	102.08	104.05	3.28	5.82	18.67	8.63	2.44	1.69	1.97
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	30.33	12.61	3.00	2.40	0.30	1.80	2.10	1.80	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	43.80	7.77	0.82	0.82	2.38	4.39	0.09	0.18	0.18
gall bladder, adult	10198-103E9	36.21	19.56	6.52	2.90	4.59	0.72	0.48	0.24	0.24
gamma delta positive T cells, donor1	11937-126A2	48.32	1.61	0.00	0.54	0.54	3.76	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	41.46	36.60	0.00	0.75	8.22	1.87	0.75	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.22	5.07	2.96	1.48	0.42	2.11	1.06	0.42	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	20.50	63.63	2.71	2.51	2.32	0.39	0.77	1.16	0.00
gastric cancer cell line:AZ521	10549-107H9	53.94	55.09	1.80	2.62	4.43	2.62	1.31	0.66	0.49
gastric cancer cell line:GSS	10560-108A2	23.80	17.39	0.00	0.00	2.75	4.58	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	26.27	31.76	0.23	3.88	4.11	1.14	0.23	0.46	0.23
giant cell carcinoma cell line:LU65	10487-107B1	15.38	10.56	0.23	0.46	2.18	0.69	0.00	0.00	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	39.61	11.34	2.52	1.26	1.82	3.64	0.14	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	14.22	13.22	1.50	1.50	1.25	0.75	0.75	0.50	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	26.39	12.24	3.17	2.74	2.32	1.58	1.16	0.32	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	31.60	14.18	3.51	4.35	2.67	1.97	1.40	0.00	0.14
glioblastoma cell line:T98G	10485-107A8	13.80	5.08	0.11	0.33	1.77	1.10	0.00	0.00	0.00
glioma cell line:GI-1	10413-106B8	29.58	22.55	0.59	2.93	3.51	1.17	1.46	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	80.18	88.93	5.83	4.37	13.85	12.39	1.46	2.92	2.19
globus pallidus, adult, donor10252	10161-103A8	105.45	68.83	2.93	3.17	6.35	8.54	3.17	1.22	0.24
globus pallidus, adult, donor10258	10367-105F7	34.23	35.60	5.48	5.48	2.74	4.11	1.37	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	34.64	77.27	2.66	2.66	7.46	0.53	0.00	2.13	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	56.28	0.00	2.45	2.45	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	12.80	8.64	0.32	0.32	1.60	0.96	0.32	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	27.09	4.59	0.46	0.92	0.46	1.84	0.46	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	18.75	4.12	0.46	0.46	0.00	3.20	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	14.17	2.58	0.64	1.29	0.00	3.86	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	10.06	1.44	1.44	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	17.83	0.69	0.00	0.69	0.69	4.12	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	40.83	45.24	2.21	4.41	8.83	5.52	0.00	0.00	2.21
hairy cell leukemia cell line:Mo	10712-109I1	28.73	6.61	0.86	0.57	1.44	1.15	0.00	0.29	0.00
heart - mitral valve, adult	10205-103F7	31.39	35.28	7.77	3.59	2.99	0.90	1.20	1.20	0.00
heart - pulmonic valve, adult	10206-103F8	34.25	32.42	4.97	4.71	3.40	0.78	1.83	0.52	0.26
heart - tricuspid valve, adult	10207-103F9	19.98	3.33	6.66	5.00	0.00	0.83	1.67	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	35.91	35.30	3.47	5.10	4.49	1.02	1.63	1.84	1.02
heart, adult, diseased, donor1	10051-101G6	22.57	56.64	3.83	2.98	4.68	0.00	1.28	0.00	0.43
heart, adult, pool1	10016-101C7	30.13	58.64	4.60	3.91	2.99	0.92	1.84	1.61	0.46
heart, fetal, pool1	10046-101G1	81.73	65.41	4.72	4.93	7.19	3.18	2.36	3.39	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	19.13	7.40	0.00	0.31	1.23	0.93	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	11.89	1.19	0.00	1.19	0.00	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	21.66	4.42	1.33	3.65	0.66	0.88	0.99	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	30.59	4.85	1.46	3.40	0.49	0.73	0.73	0.00	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	27.69	5.56	1.82	2.73	0.81	1.72	0.91	0.10	0.00
hepatoma cell line:Li-7	10484-107A7	13.68	29.58	0.67	2.22	2.45	0.22	0.56	1.00	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	29.55	2.91	0.10	1.71	0.20	1.31	0.20	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	73.81	112.61	1.89	5.68	14.19	9.46	1.89	0.95	2.84
hippocampus, adult, donor10252	10153-102I9	75.52	61.23	3.47	6.53	7.14	5.10	2.45	0.82	1.22
hippocampus, adult, donor10258	10374-105G5	30.87	49.30	1.99	3.98	16.93	9.96	1.00	1.99	1.49
hippocampus, newborn, donor10223	10363-105F3	35.25	71.20	2.47	3.17	11.98	3.17	1.06	3.17	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	58.59	6.71	0.61	3.66	0.61	3.66	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	27.88	2.55	0.39	1.57	0.00	2.55	0.00	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	34.02	3.55	0.00	0.76	0.25	2.03	0.00	0.51	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	32.14	4.51	0.00	0.56	1.69	2.82	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	35.89	8.26	1.03	1.81	3.61	3.87	1.03	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	37.96	8.73	0.76	1.52	4.93	6.45	0.00	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	32.70	31.82	4.67	4.96	3.80	4.96	1.75	0.29	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	34.68	36.84	4.09	4.52	3.02	3.66	3.88	0.43	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	32.11	26.69	2.09	5.42	2.50	3.75	1.25	0.42	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	36.47	28.65	4.26	5.68	4.74	1.89	2.84	0.95	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	28.45	30.38	3.86	5.14	3.54	2.73	2.25	0.64	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	37.03	32.99	6.06	10.10	3.37	2.69	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	30.67	4.07	0.47	1.10	0.00	1.88	0.31	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	33.90	7.37	1.97	2.46	0.00	0.49	0.49	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	47.13	9.60	0.00	0.87	0.00	4.36	1.75	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	35.89	14.51	1.53	2.29	4.77	7.64	0.57	0.00	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	31.83	9.59	0.44	2.18	4.36	3.92	0.87	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	49.98	23.99	3.00	2.00	7.00	6.50	0.00	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	23.74	38.06	14.13	7.54	5.27	3.39	7.35	0.38	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	21.37	40.92	19.55	7.73	7.73	6.82	7.28	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	20.36	33.52	14.72	5.33	5.95	4.07	5.95	0.63	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	23.35	36.58	9.31	5.23	4.90	1.80	3.43	0.00	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	23.81	35.13	10.16	5.23	4.94	0.87	4.94	0.00	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	20.03	35.87	10.16	3.89	5.08	0.90	3.29	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	34.55	3.14	0.55	0.74	0.00	1.29	0.18	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	26.82	2.57	0.29	1.43	0.57	1.71	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	42.46	3.67	0.41	2.86	0.00	4.49	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	32.39	19.01	3.52	3.52	4.58	3.87	0.35	0.70	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	26.29	9.82	0.32	0.63	0.95	3.80	0.32	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	26.33	13.62	1.82	2.42	2.42	4.54	0.61	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	18.10	24.30	4.14	3.10	3.62	6.72	2.07	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	13.28	27.23	9.30	1.33	5.98	2.66	3.32	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	18.73	28.48	3.59	4.36	4.10	2.57	1.28	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	26.33	22.75	3.83	1.79	3.58	2.05	0.77	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	29.53	24.23	4.54	4.54	5.30	2.27	5.30	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	26.55	29.57	4.37	3.36	3.70	2.02	0.34	1.01	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	26.32	0.72	0.24	1.45	0.00	2.42	0.24	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	34.76	1.78	0.45	2.67	0.89	2.23	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	35.61	0.98	0.00	1.46	0.00	2.44	0.00	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	29.95	7.64	1.22	0.92	1.22	3.97	0.61	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	312.31	29.28	6.51	32.53	19.52	39.04	3.25	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	44.35	10.59	1.65	3.31	1.65	10.59	0.66	0.00	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	26.27	29.01	7.11	6.57	6.02	6.02	3.28	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	27.50	25.33	6.88	7.96	1.81	6.51	1.81	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	24.91	25.98	7.12	3.91	3.91	1.42	2.49	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	22.67	26.25	4.77	5.97	3.58	4.77	1.19	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	39.27	40.76	8.53	5.55	5.96	5.82	3.79	0.41	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	22.63	22.90	4.31	1.89	2.96	4.04	0.81	0.27	0.00
immature langerhans cells, donor1	11904-125F5	11.14	6.30	4.36	3.63	1.21	0.73	1.45	0.00	0.00
immature langerhans cells, donor2	11905-125F6	20.60	15.05	7.92	3.17	0.00	0.79	0.79	1.58	0.00
insula, adult, pool1	10039-101F3	107.60	108.45	3.60	7.00	19.21	9.18	2.46	1.99	3.31
keratoacanthoma cell line:HKA-1	10791-110H8	27.96	9.75	1.63	1.95	0.65	0.98	0.65	0.00	0.00
kidney, adult, pool1	10017-101C8	34.34	9.71	30.64	13.12	0.60	0.40	9.61	0.10	0.00
kidney, fetal, pool1	10045-101F9	31.62	6.37	9.83	6.22	0.92	2.19	4.46	0.14	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	40.76	12.64	13.63	9.09	1.99	0.71	4.97	0.43	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	14.52	18.11	2.07	2.35	1.24	0.41	0.55	1.11	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	14.13	7.34	0.00	0.00	1.65	0.55	0.00	0.37	0.00
left atrium, adult, donor1	10079-102A7	22.88	37.59	1.63	1.63	5.45	1.09	2.18	0.54	0.00
left ventricle, adult, donor1	10078-102A6	17.19	45.51	2.53	1.01	3.54	0.00	1.01	1.01	0.51
leiomyoblastoma cell line:G-402	10721-110A1	15.32	0.00	1.09	1.64	0.00	0.55	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	15.45	6.47	2.51	1.44	1.08	0.36	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	22.28	3.26	1.63	1.63	1.63	1.09	0.00	1.09	0.00
leiomyoma cell line:15425	10571-108B4	25.74	5.58	3.16	2.43	0.73	1.46	0.24	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	12.70	0.00	0.00	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	0.00	2.09	3.14	1.05	0.00	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	11.69	10.15	0.12	0.35	1.89	0.12	0.00	0.24	0.00
liposarcoma cell line:KMLS-1	10782-110G8	26.40	7.65	5.62	4.69	0.47	1.09	1.56	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	13.89	6.70	0.00	0.73	0.37	0.85	0.12	0.00	0.12
liver, adult, pool1	10018-101C9	33.22	1.62	5.02	4.86	0.32	0.32	1.62	0.00	0.00
liver, fetal, pool1	10086-102B5	15.99	15.05	0.94	1.88	0.94	0.00	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	72.47	95.37	4.67	5.10	13.12	6.71	2.19	2.19	1.31
locus coeruleus, adult, donor10252	10165-103B3	81.20	72.16	2.77	4.24	8.67	6.64	1.29	1.11	1.11
locus coeruleus, adult, donor10258	10375-105G6	49.09	59.53	7.05	2.82	10.44	2.54	0.56	2.26	1.41
locus coeruleus, newborn, donor10223	10362-105F2	76.13	69.82	6.73	7.99	7.99	3.36	2.52	3.36	0.42
lung adenocarcinoma cell line:A549	10499-107C4	28.23	72.10	1.94	3.18	5.26	0.83	0.14	0.42	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	42.74	3.45	0.69	1.38	2.07	4.14	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	37.17	2.37	1.05	0.66	0.13	3.43	0.92	0.13	0.00
lung, adult, pool1	10019-101D1	28.82	3.43	3.66	3.43	1.89	0.83	1.65	0.35	0.00
lung, fetal, donor1	10068-101I5	80.77	25.69	10.56	10.85	4.85	5.42	2.00	0.86	0.29
lung, right lower lobe, adult, donor1	10075-102A3	37.57	1.37	13.75	3.21	2.75	2.29	0.92	0.00	0.46
lymph node, adult, donor1	10077-102A5	17.51	0.47	5.68	0.95	0.00	0.00	1.42	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	41.21	0.00	0.22	0.66	0.00	0.88	0.66	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	84.22	4.23	0.45	1.66	0.30	7.40	0.00	0.30	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	24.64	43.32	1.70	1.70	1.70	0.85	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	41.29	4.44	10.21	6.22	0.00	1.33	3.55	0.00	0.00
mature adipocyte, donor2	12232-129F9	51.26	3.32	6.23	5.19	0.00	2.28	0.83	0.00	0.00
mature adipocyte, donor3	12233-129G1	49.55	3.08	5.93	4.74	0.47	2.13	1.42	0.00	0.00
mature adipocyte, donor4	12234-129G2	51.06	1.58	7.63	3.42	0.00	2.90	1.32	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	60.28	99.59	5.72	5.48	11.91	2.14	1.19	0.48	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	92.50	126.34	1.13	2.26	31.58	5.64	2.26	3.38	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	79.08	79.82	2.76	3.31	14.34	5.89	2.21	0.74	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	55.28	99.12	3.18	2.86	20.33	5.40	0.32	1.59	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	100.22	203.86	6.82	11.52	33.27	10.24	2.13	5.54	3.84
medial temporal gyrus - adult, donor10196	10183-103D3	74.93	133.14	6.92	5.40	17.89	5.06	1.35	1.86	1.86
medial temporal gyrus, adult, donor10252	10156-103A3	65.58	73.01	3.18	4.24	13.37	6.37	1.49	0.64	2.12
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	40.45	42.38	1.93	3.85	9.63	13.48	1.93	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	904.28	459.32	28.71	71.77	71.77	57.41	43.06	0.00	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	47.02	79.68	0.72	2.87	11.13	6.82	0.36	1.44	2.15
medulla oblongata - adult, donor10196	10174-103C3	75.93	86.31	4.54	6.49	17.52	5.84	0.65	2.60	3.24
medulla oblongata, adult, donor10252	10155-103A2	78.02	58.21	3.10	4.80	10.99	6.04	1.39	1.86	1.55
medulla oblongata, adult, pool1	10038-101F2	92.40	77.95	3.92	5.96	12.16	8.90	2.86	1.88	2.04
medulla oblongata, newborn, donor10223	10361-105F1	55.55	42.01	2.43	2.43	8.68	3.12	1.39	1.04	1.04
medulloblastoma cell line:D283 Med	10838-111E1	71.07	50.26	1.11	2.21	5.09	6.42	0.66	0.22	0.89
medulloblastoma cell line:ONS-76	10759-110E3	14.67	1.10	0.12	0.12	0.24	0.73	0.00	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	89.99	79.64	0.86	1.58	8.34	5.89	0.00	2.73	0.29
melanoma cell line:G-361	10465-106H6	27.15	19.27	2.17	1.36	1.09	0.54	1.36	1.09	0.00
meningioma cell line:HKBMM	10691-109F7	13.75	3.62	0.72	0.18	0.36	0.36	0.54	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	67.85	8.81	0.88	0.88	0.00	5.29	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	48.47	9.59	0.26	0.52	1.30	4.15	0.26	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	24.09	7.98	4.60	2.61	0.61	0.92	0.77	0.00	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	19.81	6.18	2.36	2.00	0.36	0.91	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	16.56	7.04	2.90	4.14	1.66	0.83	2.07	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	27.25	7.59	4.07	2.39	0.14	1.26	0.84	0.56	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	17.72	5.20	3.85	4.24	0.96	0.96	0.96	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	27.76	9.02	2.78	2.08	0.69	1.39	0.69	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	20.42	22.48	3.43	2.40	3.43	0.34	0.34	0.34	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	21.16	7.48	3.68	2.53	1.04	0.92	0.46	0.35	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	19.76	10.35	2.79	2.65	0.80	0.53	0.66	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	26.33	9.59	5.40	2.70	0.95	0.27	0.81	0.14	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	32.01	14.65	2.28	2.70	2.42	0.85	0.43	0.43	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	34.58	22.40	4.61	2.31	1.98	1.32	0.99	0.99	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	28.92	11.21	2.63	3.46	0.69	1.11	0.55	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	17.11	11.87	4.54	2.09	2.09	0.35	0.70	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	23.27	6.33	0.82	0.20	1.02	1.84	0.00	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	23.72	13.30	2.88	1.80	1.80	0.72	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	23.48	6.72	1.55	1.34	1.03	0.93	0.83	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	16.87	3.65	1.14	0.91	0.23	0.91	0.46	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	49.93	18.04	7.13	4.20	3.36	1.68	0.00	0.84	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	26.30	10.16	2.09	2.24	1.49	0.60	0.00	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	24.77	12.08	2.01	1.93	1.66	0.96	0.44	0.18	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	25.40	10.68	2.58	1.10	3.68	1.10	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	22.61	5.72	1.14	0.00	0.57	0.86	0.00	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	18.10	1.68	0.84	0.00	0.00	1.68	0.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.53	5.94	2.28	0.46	2.28	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	21.49	6.91	3.58	2.05	0.77	1.28	1.28	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	18.06	3.66	4.71	1.05	1.31	0.26	0.79	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.10	4.93	6.47	2.16	0.31	1.54	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	16.95	5.41	4.47	0.94	1.18	1.65	0.71	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	19.63	6.77	4.06	1.69	0.34	1.02	1.35	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	15.33	3.14	4.72	2.75	1.18	1.18	0.00	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	12.97	6.49	3.24	1.39	0.46	0.93	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	24.52	9.81	6.92	3.17	2.60	0.87	1.15	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	14.72	4.91	3.12	1.12	0.89	0.67	1.34	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	15.38	7.45	4.57	2.64	0.96	0.48	0.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	23.47	3.67	5.13	4.40	0.00	1.47	1.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	11.75	4.03	2.69	2.69	0.67	0.67	0.67	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	14.74	6.96	4.50	1.64	0.41	0.82	0.41	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	20.19	4.73	3.87	1.72	0.86	1.72	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	5.47	0.00	0.00	0.00	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	18.19	6.50	3.57	1.62	0.32	0.97	0.97	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	10.18	4.36	2.91	4.36	0.00	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	22.39	7.46	6.40	2.13	2.13	1.60	0.53	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	16.36	6.54	4.91	1.64	0.82	0.82	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.55	5.44	5.83	0.78	0.00	0.78	0.39	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	8.39	6.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	18.88	3.97	3.97	4.97	1.99	0.00	0.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	9.53	0.00	0.00	0.00	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	8.30	7.12	2.96	2.96	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	14.62	8.53	1.22	0.00	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	15.83	10.13	3.80	2.53	0.63	0.63	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	25.18	6.55	5.17	1.72	1.03	1.03	0.69	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	8.60	4.30	2.15	0.00	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	3.99	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	3.44	6.89	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	15.48	2.04	2.44	0.81	0.41	0.81	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	16.68	2.38	4.77	0.00	0.00	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.38	0.59	2.36	0.59	0.00	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	19.01	2.81	5.30	0.31	0.00	1.25	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	16.04	1.34	1.34	4.01	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	28.38	0.00	1.18	2.37	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	0.00	0.00	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	13.08	2.07	2.07	2.07	0.00	0.69	0.00	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	23.75	6.93	0.99	1.48	0.00	0.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	20.19	3.36	0.00	0.00	1.12	1.12	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	19.72	3.18	2.54	0.64	0.00	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	19.34	6.04	1.61	0.40	0.00	0.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	4.36	2.18	0.00	0.00	0.00	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	5.07	0.00	0.00	0.00	1.27	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.24	34.59	4.25	3.64	4.25	2.43	0.00	1.21	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	58.75	4.52	0.00	0.00	0.00	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.83	43.66	1.65	0.82	5.77	0.82	0.82	0.82	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	26.19	5.56	2.78	0.99	0.60	1.59	0.40	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	16.22	3.24	0.65	2.27	0.00	0.65	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	18.34	3.06	2.04	0.00	1.02	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	25.53	1.55	0.00	0.77	0.77	1.55	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	19.37	9.92	3.78	3.78	0.94	1.65	1.89	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	29.42	1.16	4.17	2.55	0.00	0.93	0.23	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	4.27	0.00	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	22.09	3.49	1.13	1.13	0.31	1.03	0.10	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	13.16	11.57	0.68	0.45	0.68	0.45	0.45	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	14.18	2.69	0.73	0.98	1.22	0.24	0.00	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	17.05	3.76	0.44	1.55	1.33	0.22	0.44	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	14.19	9.72	3.42	1.31	0.53	0.26	0.26	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	19.06	1.70	0.85	0.85	1.02	0.85	0.00	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	4.55	1.01	0.76	0.00	0.00	0.25	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	13.04	4.76	2.69	2.07	0.83	0.62	0.21	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	16.56	3.48	0.50	0.50	0.17	0.33	0.33	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	19.00	0.72	2.17	1.45	0.00	0.90	0.72	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	16.06	6.32	3.07	1.88	1.37	0.68	0.00	0.51	0.00
mesothelioma cell line:NCI-H28	10845-111E8	9.92	7.89	1.78	2.54	1.27	0.76	1.02	0.00	0.00
mesothelioma cell line:No36	10857-111G2	15.33	12.72	1.96	2.94	2.28	0.65	0.00	0.98	0.00
mesothelioma cell line:ONE58	10858-111G3	9.48	2.44	0.27	0.00	0.00	0.54	0.00	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	20.54	9.98	2.49	8.25	1.15	0.96	1.15	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	32.73	11.85	1.10	3.79	1.71	2.20	0.61	0.61	0.00
migratory langerhans cells, donor3	11903-125F4	26.56	5.38	1.79	4.85	1.08	2.33	0.54	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	12.41	3.59	1.31	1.31	1.31	0.00	0.65	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	12.72	9.96	0.85	1.06	0.64	0.00	0.85	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	16.59	14.28	0.46	0.00	0.46	0.46	0.00	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	14.27	4.95	0.38	0.95	0.00	0.95	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	51.74	0.00	0.18	0.74	0.00	4.44	0.18	0.00	0.00
myeloma cell line:PCM6	10474-106I6	55.74	0.00	0.79	1.38	0.00	1.78	0.40	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	9.64	2.03	1.52	0.51	0.00	1.52	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	16.48	4.51	1.77	1.37	0.59	0.39	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	29.42	29.42	1.23	0.67	4.01	0.89	0.56	0.89	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	34.42	42.58	1.62	0.88	5.88	1.76	0.66	1.25	0.59
nasal epithelial cells, donor2	12227-129F4	12.70	15.46	3.31	1.66	2.76	0.00	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	85.58	130.67	0.23	1.15	9.66	9.66	0.00	0.46	0.46
neuroblastoma cell line:NB-1	10539-107G8	75.96	146.30	14.97	15.53	12.16	2.99	3.93	2.62	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	33.32	43.23	0.00	0.84	3.37	1.48	0.42	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	65.97	27.02	0.56	1.49	4.29	5.96	0.00	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	71.17	41.04	0.95	2.37	1.42	2.61	0.95	0.24	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	86.00	29.62	2.38	3.48	1.58	3.64	0.16	0.63	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	27.37	14.69	0.20	1.21	1.01	0.81	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	19.71	11.44	0.00	0.00	0.00	1.27	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	13.57	3.46	3.99	0.80	0.53	1.06	0.27	0.00	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	51.41	0.34	0.00	0.00	0.00	9.98	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	19.21	37.62	0.00	0.00	6.40	0.00	0.80	1.60	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	22.12	5.77	3.21	0.96	0.96	1.92	0.64	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	20.50	3.94	2.36	4.20	1.05	1.05	1.05	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	97.58	80.99	4.22	5.53	16.12	7.87	1.87	2.16	2.06
occipital cortex - adult, donor10196	10172-103C1	103.02	152.47	16.48	8.24	22.66	8.24	4.12	2.06	4.12
occipital cortex, adult, donor10252	10163-103B1	80.24	77.02	3.22	4.29	9.66	5.37	2.15	1.34	1.07
occipital cortex, newborn, donor10223	10355-105E4	44.40	90.99	3.28	3.28	12.74	5.10	0.73	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	76.36	120.70	3.94	3.15	12.33	6.56	1.84	0.79	2.62
occipital lobe, fetal, donor1	10073-102A1	63.94	112.00	0.86	2.15	17.16	11.16	0.43	1.72	2.57
occipital pole, adult, pool1	10036-101E9	53.69	49.51	1.81	2.76	10.49	6.31	1.26	0.79	1.34
olfactory region, adult	10195-103E6	48.53	59.99	3.25	3.25	12.04	7.26	1.72	0.76	1.34
optic nerve, donor1	10277-104E7	98.05	132.07	8.00	2.00	8.00	10.01	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	40.55	19.25	2.85	3.99	2.51	1.48	0.91	0.34	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	13.05	5.08	0.14	0.27	0.00	1.51	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	19.98	7.96	5.25	1.86	0.34	0.68	0.51	0.34	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	13.17	6.12	1.27	0.46	0.58	0.23	0.46	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	25.28	5.00	0.29	1.18	0.59	0.29	0.29	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	20.56	3.74	1.87	0.93	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	38.81	7.00	2.12	1.91	0.42	2.12	0.21	0.00	0.00
ovary, adult, pool1	10020-101D2	30.22	6.73	3.84	4.37	0.79	0.70	1.75	0.00	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	21.82	2.93	0.55	0.55	0.18	0.73	0.00	0.18	0.18
pancreas, adult, donor1	10049-101G4	49.85	17.87	6.58	8.47	4.70	1.88	1.88	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	32.99	2.24	0.84	3.91	0.56	0.28	1.68	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	16.86	3.75	1.53	1.87	1.36	0.85	0.51	0.00	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	50.83	19.54	1.99	0.50	2.15	1.99	0.00	0.50	0.17
paracentral gyrus, adult, pool1	10035-101E8	93.81	91.06	2.38	3.66	15.47	10.62	1.65	1.65	1.74
parietal cortex, adult, donor10258	10373-105G4	52.11	69.00	2.20	2.94	15.41	5.14	0.73	0.00	2.20
parietal lobe - adult, donor10196	10171-103B9	79.94	99.69	0.94	3.76	18.81	6.58	1.88	0.94	1.88
parietal lobe, adult, donor10252	10157-103A4	69.55	74.11	2.00	7.13	13.11	4.56	2.00	1.14	2.28
parietal lobe, adult, pool1	10034-101E7	93.05	88.03	3.08	4.67	16.57	8.72	1.85	2.11	2.20
parietal lobe, fetal, donor1	10072-101I9	83.41	135.78	4.85	0.97	14.55	9.70	2.91	0.97	1.94
parietal lobe, newborn, donor10223	10356-105E5	45.24	78.88	5.98	4.86	11.59	3.74	0.00	1.50	0.00
parotid gland, adult	10199-103F1	75.85	73.38	3.08	0.62	9.25	0.62	0.62	14.80	0.00
penis, adult	10200-103F2	27.39	5.91	7.52	1.07	0.00	1.07	0.54	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	21.20	140.20	3.16	4.09	11.71	0.37	1.12	7.25	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	31.62	15.01	2.19	1.60	2.19	1.31	0.15	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	42.57	240.60	6.45	10.97	33.54	4.52	4.52	7.10	9.03
pineal gland, adult, donor10252	10160-103A7	180.03	427.58	5.33	19.54	110.15	7.70	4.74	11.25	10.66
pineal gland, adult, donor10258	10377-105G8	59.57	228.26	2.51	4.39	58.32	5.02	3.14	8.78	9.41
pituitary gland - adult, donor10196	10180-103C9	110.29	132.55	11.13	9.11	33.39	2.02	4.05	4.05	3.04
pituitary gland, adult, donor10252	10162-103A9	193.88	183.98	4.69	14.59	35.44	5.21	3.65	7.30	3.13
pituitary gland, adult, donor10258	10378-105G9	105.55	88.53	4.26	5.11	27.24	5.11	2.55	1.70	2.55
placenta, adult, pool1	10021-101D3	50.63	11.50	9.25	4.30	1.29	1.40	1.72	0.54	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	27.81	4.11	0.13	0.66	1.19	2.38	0.00	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	42.49	4.36	0.78	1.09	1.87	2.33	0.16	0.00	0.00
pons, adult, pool1	10033-101E6	99.15	89.42	3.27	4.82	16.35	11.27	1.12	2.58	2.07
postcentral gyrus, adult, pool1	10032-101E5	69.91	83.08	2.79	3.84	13.86	6.89	2.18	1.39	1.57
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.48	3.64	1.17	1.75	0.29	1.17	0.29	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	37.57	15.06	7.99	4.54	1.63	1.09	0.91	0.91	0.00
prostate, adult, pool1	10022-101D4	33.47	12.97	5.08	4.08	1.45	1.54	1.18	0.63	0.18
putamen, adult, donor10196	10176-103C5	73.65	84.98	5.67	3.30	13.69	5.90	3.78	1.42	0.94
putamen, adult, donor10252	10152-102I8	66.66	74.51	1.96	0.00	9.80	1.96	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	31.69	18.58	3.28	0.00	6.56	5.46	1.09	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	43.49	59.92	3.14	3.14	11.11	4.35	0.72	0.97	0.97
putamen, newborn, donor10223	10365-105F5	102.70	145.43	7.50	9.00	9.00	9.00	3.00	6.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	30.26	42.48	1.45	4.36	2.04	2.33	0.58	1.45	0.00
rectum, fetal, donor1	10067-101I4	47.29	23.65	4.17	0.00	5.56	2.78	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	31.16	5.30	0.42	0.85	0.21	1.06	0.21	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	51.78	36.86	4.97	1.66	4.56	1.66	0.83	1.24	0.00
retina, adult, pool1	10030-101E3	60.14	52.28	10.14	5.47	14.11	3.28	3.78	3.58	2.98
retinoblastoma cell line:Y79	10475-106I7	70.15	31.96	0.26	0.78	3.64	6.75	0.00	0.26	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	21.39	8.85	4.18	2.46	0.37	0.74	1.48	0.12	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	39.37	12.94	0.84	1.97	0.56	3.37	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	21.22	1.52	2.27	0.76	0.00	0.00	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	21.04	3.56	3.72	2.43	0.49	1.94	1.13	0.00	0.00
salivary acinar cells, donor2	11772-123I8	21.89	5.92	7.44	1.93	0.55	0.96	0.83	0.28	0.00
salivary acinar cells, donor3	11773-123I9	28.47	17.21	9.93	2.65	0.66	1.32	0.66	1.32	0.00
salivary gland, adult, pool1	10093-102C3	105.81	151.00	14.30	8.01	20.02	2.29	3.43	48.04	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	25.55	15.18	2.19	2.95	2.78	0.84	0.93	0.42	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	30.80	17.40	3.41	2.47	1.65	0.47	1.76	0.82	0.24
seminal vesicle, adult	10201-103F3	32.80	26.98	19.58	2.12	1.59	1.59	1.06	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	16.52	1.46	0.73	0.73	0.00	0.73	0.24	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	11.32	5.54	1.01	0.75	0.00	0.25	0.00	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	27.10	3.01	0.00	0.00	2.01	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	31.16	1.75	0.40	0.40	0.13	2.15	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	15.69	80.80	0.44	0.66	7.41	1.11	0.55	1.88	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	38.97	68.13	1.55	2.58	5.94	0.65	0.65	3.23	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	21.28	2.13	4.26	2.13	0.00	1.42	1.42	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	39.22	9.83	3.72	2.04	0.36	0.24	1.44	0.96	0.12
skeletal muscle, fetal, donor1	10066-101I3	21.11	5.03	1.01	2.01	0.00	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	13.57	13.57	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	58.70	27.14	7.57	3.16	3.16	3.79	3.16	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	46.36	15.68	0.33	0.67	2.67	4.00	0.33	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	34.36	35.62	4.10	5.36	3.15	0.32	0.95	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	42.21	1.16	0.58	0.77	0.19	3.08	0.77	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	28.52	35.44	6.76	2.47	3.79	1.65	2.14	0.33	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	53.88	28.63	0.16	1.13	8.53	7.08	0.16	0.32	2.25
small cell lung carcinoma cell line:WA-hT	10562-108A4	29.64	32.91	4.79	5.45	1.74	0.87	2.83	1.31	0.00
small intestine, adult, pool1	10024-101D6	53.27	41.09	3.46	3.22	5.14	0.60	0.84	1.07	0.12
small intestine, fetal, donor1	10064-101I1	44.23	26.04	3.44	0.98	1.97	1.23	0.25	0.25	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	20.00	11.28	1.54	0.00	1.03	1.54	1.03	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	25.85	9.56	2.84	3.10	1.29	0.78	0.78	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	30.02	47.17	1.07	1.61	3.22	0.27	0.54	0.80	0.00
spinal cord - adult, donor10196	10181-103D1	96.12	134.43	9.86	6.19	9.64	8.49	3.44	2.29	0.92
spinal cord, adult, donor10252	10159-103A6	128.93	95.02	3.94	5.91	7.10	8.67	3.15	1.18	1.18
spinal cord, adult, donor10258	10369-105F9	83.71	85.09	10.38	12.45	15.22	19.37	2.77	2.08	1.38
spinal cord, fetal, donor1	10056-101H2	72.57	93.91	8.54	4.88	8.54	10.98	3.05	0.00	1.83
spinal cord, newborn, donor10223	10359-105E8	105.16	111.59	6.89	6.89	14.69	6.43	3.67	1.84	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	16.58	2.84	1.79	0.90	0.30	0.00	0.60	0.15	0.15
spleen, adult, pool1	10025-101D7	29.74	3.63	10.46	5.07	0.55	0.88	1.98	0.11	0.11
spleen, fetal, pool1	10044-101F8	30.43	12.63	6.83	4.85	2.86	2.07	2.46	0.79	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	29.50	3.21	0.10	1.45	0.21	2.07	0.41	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	32.66	31.52	5.51	3.04	2.28	2.09	1.14	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	60.11	56.26	10.13	15.03	6.99	1.05	4.89	2.45	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	23.46	8.21	1.17	0.39	1.95	1.17	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	189.89	140.02	2.14	5.74	18.01	5.52	1.91	6.08	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	22.03	11.44	0.85	0.00	2.12	1.27	0.85	1.69	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	7.62	3.81	9.31	1.69	0.00	0.00	0.42	0.42	0.00
stomach, fetal, donor1	10062-101H8	14.95	10.68	10.68	2.14	2.14	0.00	3.20	0.00	2.14
submaxillary gland, adult	10202-103F4	71.21	92.86	4.56	10.25	7.98	2.28	4.56	19.37	1.71
substantia nigra - adult, donor10196	10178-103C7	162.82	108.55	0.00	0.00	54.27	54.27	108.55	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	111.54	87.03	2.49	2.49	8.93	6.02	0.83	1.04	1.66
substantia nigra, adult, donor10258	10371-105G2	55.86	58.45	4.14	3.10	20.69	10.86	0.52	2.07	0.00
substantia nigra, newborn, donor10223	10358-105E7	49.46	78.43	4.95	4.95	7.07	4.95	0.71	2.12	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	33.24	3.67	2.06	2.52	0.00	2.98	0.69	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	58.15	59.68	2.37	3.05	10.26	4.92	1.44	1.02	1.19
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	71.23	73.36	0.71	2.85	8.55	7.83	0.71	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	50.11	51.87	2.20	1.32	8.35	5.71	0.44	0.88	1.32
tenocyte, donor1	11763-123H8	18.50	2.44	3.14	1.05	0.00	0.00	1.40	0.00	0.00
tenocyte, donor2	11765-123I1	11.83	1.53	3.82	2.29	0.00	1.53	0.38	0.00	0.00
tenocyte, donor3	11768-123I4	20.39	0.74	3.71	1.48	0.00	0.74	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	43.34	5.10	2.04	5.44	0.51	1.87	1.02	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	18.19	3.39	0.00	0.15	0.15	1.85	0.15	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	47.11	6.35	0.31	1.08	0.15	3.56	0.31	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	29.83	5.71	1.90	3.05	0.51	0.38	1.40	0.13	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	45.38	15.51	0.76	3.03	2.65	3.03	0.38	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	34.35	3.82	3.60	3.27	0.00	0.55	1.20	0.11	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	42.99	0.98	0.98	4.89	0.00	4.56	0.65	0.00	0.00
testis, adult, pool1	10026-101D8	48.00	51.22	7.84	6.23	4.62	2.58	2.90	1.18	0.00
testis, adult, pool2	10096-102C6	48.72	57.74	11.28	5.41	9.02	2.26	3.61	2.26	0.00
thalamus - adult, donor10196	10168-103B6	91.63	126.96	4.42	5.52	11.04	6.62	1.10	1.10	3.31
thalamus, adult, donor10252	10154-103A1	102.83	67.98	3.59	2.50	8.91	7.19	1.88	1.09	2.34
thalamus, adult, donor10258, tech_rep1	10370-105G1	38.49	41.57	3.08	4.62	18.48	7.70	0.00	6.16	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	31.46	37.38	4.28	2.31	4.78	2.64	0.66	0.99	1.32
thalamus, newborn, donor10223	10366-105F6	50.63	107.01	14.38	8.05	11.51	1.73	1.73	3.45	1.15
throat, adult	10209-103G2	35.20	21.97	9.24	2.25	2.75	0.50	1.75	1.50	0.50
throat, fetal, donor1	10061-101H7	35.96	13.41	6.40	6.40	0.91	2.13	3.05	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	55.45	9.74	1.19	0.79	1.19	3.18	0.40	0.20	0.00
thymus, adult, pool1	10027-101D9	57.56	6.56	1.29	1.09	0.20	3.88	0.30	0.00	0.10
thymus, fetal, pool1	10043-101F7	56.11	10.60	1.56	3.01	1.14	2.81	1.04	0.31	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	21.41	6.91	0.93	1.20	1.46	1.20	0.00	0.00	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	21.93	2.65	1.96	1.40	0.70	0.56	0.84	0.14	0.28
thyroid, adult, pool1	10028-101E1	47.87	1.31	4.57	9.70	0.09	2.43	2.52	0.00	0.00
thyroid, fetal, donor1	10060-101H6	38.49	3.95	5.80	9.76	0.79	2.37	3.16	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	24.64	43.11	15.40	0.00	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	35.35	35.58	11.16	3.26	5.12	0.70	1.86	2.79	0.47
tongue, fetal, donor1	10059-101H5	31.13	36.26	6.31	1.97	5.12	1.58	0.79	1.58	0.39
tonsil, adult, pool1	10047-101G2	55.70	25.75	6.81	1.90	2.20	2.20	1.20	2.20	0.30
trachea, adult, pool1	10029-101E2	40.24	14.48	5.97	3.68	4.34	2.04	2.29	1.72	0.65
trachea, fetal, donor1	10058-101H4	31.16	20.00	4.62	5.00	1.15	3.08	2.69	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	24.80	8.50	1.06	4.25	1.06	0.35	0.71	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	29.79	12.56	0.51	0.81	1.42	1.93	0.20	0.30	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	57.66	59.70	7.52	7.05	7.52	1.88	2.82	1.25	0.78
tridermal teratoma cell line:HGRT	10694-109G1	7.61	1.90	0.00	0.00	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	15.41	25.31	4.40	2.45	2.29	0.68	1.27	0.76	0.00
umbilical cord, fetal, donor1	10057-101H3	35.47	16.69	0.00	4.17	0.00	0.00	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	36.86	8.70	9.73	7.51	1.37	2.39	1.88	0.17	0.00
uterus, fetal, donor1	10055-101H1	43.51	23.04	4.61	2.56	1.02	3.07	5.63	0.51	0.00
vagina, adult	10204-103F6	25.85	3.23	0.65	2.58	0.00	0.00	1.29	0.00	0.00
vein, adult	10191-103E2	24.33	1.53	1.32	1.53	0.66	0.66	0.66	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	16.29	0.80	0.27	0.80	0.00	0.53	0.00	0.00	0.00